
<html lang="en"     class="pb-page"  data-request-id="7d882f26-9870-4619-bf00-0c863731b26f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm400121t;requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-5;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Hepatitis C Virus NS3-4A Protease Inhibitors with Improved Barrier to Resistance and Favorable Liver Distribution" /></meta><meta name="dc.Creator" content="Benoît  Moreau" /></meta><meta name="dc.Creator" content="Jeff A.  O’Meara" /></meta><meta name="dc.Creator" content="Josée  Bordeleau" /></meta><meta name="dc.Creator" content="Michel  Garneau" /></meta><meta name="dc.Creator" content="Cedrickx  Godbout" /></meta><meta name="dc.Creator" content="Vida  Gorys" /></meta><meta name="dc.Creator" content="Mélissa  Leblanc" /></meta><meta name="dc.Creator" content="Elisia  Villemure" /></meta><meta name="dc.Creator" content="Peter W.  White" /></meta><meta name="dc.Creator" content="Montse  Llinàs-Brunet" /></meta><meta name="dc.Description" content="Given the emergence of resistance observed for the current clinical-stage hepatitis C virus (HCV) NS3 protease inhibitors, there is a need for new inhibitors with a higher barrier to resistance. We..." /></meta><meta name="Description" content="Given the emergence of resistance observed for the current clinical-stage hepatitis C virus (HCV) NS3 protease inhibitors, there is a need for new inhibitors with a higher barrier to resistance. We..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 28, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400121t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400121t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400121t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400121t" /></link>
        
    
    

<title>Discovery of Hepatitis C Virus NS3-4A Protease Inhibitors with Improved Barrier to Resistance and Favorable Liver Distribution | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400121t" /></meta><meta property="og:title" content="Discovery of Hepatitis C Virus NS3-4A Protease Inhibitors with Improved Barrier to Resistance and Favorable Liver Distribution" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0008.jpeg" /></meta><meta property="og:description" content="Given the emergence of resistance observed for the current clinical-stage hepatitis C virus (HCV) NS3 protease inhibitors, there is a need for new inhibitors with a higher barrier to resistance. We recently reported our rational approach to the discovery of macrocyclic acylsulfonamides as HCV protease inhibitors addressing potency against clinically relevant resistant variants. Using X-ray crystallography of HCV protease variant/inhibitor complexes, we shed light on the complex structural mechanisms by which the D168V and R155K residue mutations confer resistance to NS3 protease inhibitors. Here, we disclose SAR investigation and ADME/PK optimization leading to the identification of inhibitors with significantly improved potency against the key resistant variants and with increased liver partitioning." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400121t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400121t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400121t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400121t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400121t&amp;href=/doi/10.1021/jm400121t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1770-1776</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400164c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401338c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Hepatitis C Virus NS3-4A Protease Inhibitors with Improved Barrier to Resistance and Favorable Liver Distribution</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beno%C3%AEt++Moreau">Benoît Moreau</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff+A.++O%E2%80%99Meara">Jeff A. O’Meara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9e++Bordeleau">Josée Bordeleau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Garneau">Michel Garneau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cedrickx++Godbout">Cedrickx Godbout</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vida++Gorys">Vida Gorys</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=M%C3%A9lissa++Leblanc">Mélissa Leblanc</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisia++Villemure">Elisia Villemure</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+W.++White">Peter W. White</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Montse++Llin%C3%A0s-Brunet">Montse Llinàs-Brunet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Medicinal Chemistry and <sup>‡</sup>Department of Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div><div class="corresp-info"><strong>*</strong>Phone: (450) 682-4641. E-mail: <a href="/cdn-cgi/l/email-protection#1143544256747f7463707d3f7d706751737e747963787f7674633c787f76747d7974787c3f727e7c"><span class="__cf_email__" data-cfemail="d88a9d8b9fbdb6bdaab9b4f6b4b9ae98bab7bdb0aab1b6bfbdaaf5b1b6bfbdb4b0bdb1b5f6bbb7b5">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400121t&amp;href=/doi/10.1021%2Fjm400121t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1770–1776</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 18, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 January 2013</li><li><span class="item_label"><b>Published</b> online</span>28 March 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 March 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400121t" title="DOI URL">https://doi.org/10.1021/jm400121t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1770%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBeno%25C3%25AEt%2BMoreau%252C%2BJeff%2BA.%2BO%25E2%2580%2599Meara%252C%2BJos%25C3%25A9e%2BBordeleau%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D5%26contentID%3Djm400121t%26title%3DDiscovery%2Bof%2BHepatitis%2BC%2BVirus%2BNS3-4A%2BProtease%2BInhibitors%2Bwith%2BImproved%2BBarrier%2Bto%2BResistance%2Band%2BFavorable%2BLiver%2BDistribution%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1776%26publicationDate%3DMarch%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400121t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2295</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">24</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400121t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Hepatitis C Virus NS3-4A Protease Inhibitors with Improved Barrier to Resistance and Favorable Liver Distribution&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Benoît&quot;,&quot;last_name&quot;:&quot;Moreau&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;A. O’Meara&quot;},{&quot;first_name&quot;:&quot;Josée&quot;,&quot;last_name&quot;:&quot;Bordeleau&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Garneau&quot;},{&quot;first_name&quot;:&quot;Cedrickx&quot;,&quot;last_name&quot;:&quot;Godbout&quot;},{&quot;first_name&quot;:&quot;Vida&quot;,&quot;last_name&quot;:&quot;Gorys&quot;},{&quot;first_name&quot;:&quot;Mélissa&quot;,&quot;last_name&quot;:&quot;Leblanc&quot;},{&quot;first_name&quot;:&quot;Elisia&quot;,&quot;last_name&quot;:&quot;Villemure&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;W. White&quot;},{&quot;first_name&quot;:&quot;Montse&quot;,&quot;last_name&quot;:&quot;Llinàs-Brunet&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1770-1776&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400121t&quot;},&quot;abstract&quot;:&quot;Given the emergence of resistance observed for the current clinical-stage hepatitis C virus (HCV) NS3 protease inhibitors, there is a need for new inhibitors with a higher barrier to resistance. We recently reported our rational approach to the discovery of macrocyclic acylsulfonamides as HCV protease inhibitors addressing potency against clinically relevant resistant variants. Using X-ray crystallography of HCV protease variant/inhibitor complexes, we shed light on the complex structural mechanisms by which the D168V and R155K residue mutations confer resistance to NS3 protease inhibitors. Here, we disclose SAR investigation and ADME/PK optimization leading to the identification of inhibitors with significantly improved potency against the key resistant variants and with increased liver partitioning.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400121t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400121t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400121t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400121t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400121t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400121t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400121t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400121t&amp;href=/doi/10.1021/jm400121t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400121t" /></input><a href="/doi/pdf/10.1021/jm400121t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (501 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400121t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400121t%26sid%3Dliteratum%253Aachs%26pmid%3D23506530%26genre%3Darticle%26aulast%3DMoreau%26date%3D2014%26atitle%3DDiscovery%2Bof%2BHepatitis%2BC%2BVirus%2BNS3-4A%2BProtease%2BInhibitors%2Bwith%2BImproved%2BBarrier%2Bto%2BResistance%2Band%2BFavorable%2BLiver%2BDistribution%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D5%26spage%3D1770%26epage%3D1776%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jmcmar.2014.57.issue-5/production/jmcmar.2014.57.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400121t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Given the emergence of resistance observed for the current clinical-stage hepatitis C virus (HCV) NS3 protease inhibitors, there is a need for new inhibitors with a higher barrier to resistance. We recently reported our rational approach to the discovery of macrocyclic acylsulfonamides as HCV protease inhibitors addressing potency against clinically relevant resistant variants. Using X-ray crystallography of HCV protease variant/inhibitor complexes, we shed light on the complex structural mechanisms by which the D168V and R155K residue mutations confer resistance to NS3 protease inhibitors. Here, we disclose SAR investigation and ADME/PK optimization leading to the identification of inhibitors with significantly improved potency against the key resistant variants and with increased liver partitioning.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/57/5"><issue-title>HCV Therapies</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The hepatitis C virus (HCV), identified in 1989,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> infects about 130–170 million individuals worldwide and is a major cause of chronic liver disease.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The HCV NS3 protease, an essential protein required for the virus replication, was validated in 2002 as an attractive target in a clinical trial with inhibitor ciluprevir (BILN 2061).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In 2011, the first generation of HCV direct acting antivirals (DAA), protease inhibitors boceprevir<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and telaprevir,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> which contain α-keto amide warheads, were approved by the FDA. These inhibitors must be administered in combination therapy with ribavirin (RBV) and injectable pegylated interferon-α (PEG IFN-α) in order to prevent the rapid emergence of resistance. In phase III trials, for treatment naive genotype 1 infected patients, these drugs combinations improved the SVR from 45% to approximately 67–75%.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></div><div class="NLM_p">Second generation NS3 protease inhibitors, which have ionic interactions with the active site, are in advanced clinical trials. Among these, <b>1</b> (faldaprevir, BI 201335)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> is a C-terminal carboxylic acid developed by Boehringer Ingelheim and is currently completing phase III clinical trials. Common resistant variants for genotype 1 patients have been observed for <b>1</b> in the clinic. For genotype 1b, mutations encode changes at Asp168, most frequently to valine (D168V). For genotype 1a, the most common substitution occurs on the Arg155 residue to lysine (R155K), while substitutions of the Asp168 residue are also observed at higher doses.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> There is a significant overlap in the variants observed in the clinic for other second generation inhibitors. These substitutions are consistent with in vitro resistance studies performed in genotype 1a and 1b replicons.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Given the well-known interferon side effects and the emergence of resistant variants, it is expected that when new HCV drugs with alternative mechanisms are approved, the standard therapy will become an IFN-α-sparing regimen comprising two or more DAA.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In combination with other DAAs, next generation protease inhibitors with a higher barrier to resistance might significantly improve the response rate and/or simplify treatment regimens.</div><div class="NLM_p last">We recently reported crystal structures of HCV NS3 protease inhibitors bound to variants and compared the interactions with the <b>1</b>/wild type complex.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The analysis provided an understanding of the structural mechanism by which the variants confer resistance to inhibitors of HCV NS3 protease. When compound <b>1</b> is bound to wildtype NS3 protease, the Arg155 and Asp168 residues form a salt bridge that desolvates Arg155 and form a hydrophobic surface to which the quinoline moiety of the inhibitor can bind. In the mutated protease, the Arg155 and Asp168 salt bridge is disrupted, leading to the loss of the binding surface. This observation led to the design of compounds that are conformationally flexible to adapt to amino acid variation within the binding pocket and that predominantly capitalize on highly conserved residues. We reported the discovery of macrocyclic acylsulfonamides as HCV NS3 protease inhibitors addressing potency against clinically relevant resistant variants.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Here, we disclose the SAR investigation and ADME/PK optimization leading to the identification of inhibitors with significantly improved potency against the key resistant variants and with increased liver partitioning.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our first objective was to identify a HCV NS3 protease inhibitor class with enhanced potency against key resistant mutations relative to <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The in-house collection of protease inhibitors was profiled against two distinct replicons containing the targeted resistance mutations: D168V in genotype 1b and R155K in genotype 1a. We selected inhibitors that possessed smaller, more compact carbamates and/or smaller P2 proline substituents relative to <b>1</b>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This approach led to the identification of compound <b>1</b>, a tripeptide macrocycle with an acylsulfonamide active site binding group and a simplified P2-alkoxyquinoline substituent. A C-terminal acylsulfonamide was originally shown to be a replacement for the carboxylic acid by the BMS group<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and the Uppsala group.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Compound <b>2</b> exhibited a 125-fold improvement in potency for the R155K gt 1a variant compared to <b>1</b> and a 40-fold improvement for the D168V gt 1b variant. From a comparison of the in vitro profiles, <b>1</b> showed increased human liver microsomal stability and higher permeability. Thus, compound <b>2</b> represented an attractive lead structure but required improvements in both potency and ADME properties.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparison of in Vitro Profiles of <b>1</b> and Compound <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0003.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">WT gt 1b</th><th class="colsep0 rowsep0" align="center" char=".">WT gt 1a</th><th class="colsep0 rowsep0" align="center" char=".">D168V gt 1b</th><th class="colsep0 rowsep0" align="center" char=".">R155K gt 1a</th><th class="colsep0 rowsep0" align="center" char=".">HLM <i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 AB (10<sup>–6</sup> cm·s<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">5700</td><td class="colsep0 rowsep0" align="char" char=".">5000</td><td class="colsep0 rowsep0" align="char" char=".">193</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr></tbody></table></div></div><div class="NLM_p">Throughout lead optimization, a particular focus was placed on improving permeability and metabolic stability. On the basis of the structural information provided by the analysis of <b>1</b> bound to wild-type,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> the modulation of the quinoline and the N-terminal capping group, which are in proximity to the mutation sites, should have the greatest impact on the resistance profile of the inhibitors. Therefore, we focused on the SAR of the quinoline moiety and the N-terminal capping group of compound <b>2</b> in order to assess the potential to improve on the potency versus the variant relicons.</div><div class="NLM_p">A strategy was designed for the synthesis of the inhibitors to allow modifications at these two sites. All inhibitors were synthesized from the previously reported macrocyclic brosylate <b>21</b>. Inhibitors <b>2</b>–<b>20</b> were prepared as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> (see also <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Displacement of the brosylate with 2-alkoxy-4-hydroxyquinoline derivatives <b>22a</b>–<b>c</b> in the presence of cesium carbonate followed by hydrolysis of the carboxylic acid and subsequent acylsulfonamide formation with <b>23a</b>,<b>b</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> yielded compounds <b>2</b>–<b>4</b> and intermediate <b>24</b>, respectively. After removal of the Boc protecting group under acidic conditions from the appropriate intermediate (<b>2</b>, <b>3</b>, or <b>24</b>), the resulting crude amine salt was reacted with the corresponding chloroformate to give carbamates <b>5</b> and <b>6</b> or with the corresponding acid under coupling conditions to afford amides <b>7</b>–<b>20</b>. The synthesis of 2-alkoxy-4-hydroxyquinoline derivatives <b>22a</b>–<b>c</b> was carried out as outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Aniline <b>25</b> was treated with imidate <b>26</b>, prepared from ethyl cyanoacetate and the required alcohol. The resulting intermediate <b>27</b> was carefully heated to produce 2-alkoxy-4-hydroxyquinoline derivatives <b>22a</b>–<b>c</b>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>–<b>20</b> and Intermediate <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400121t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, <b>22a</b>–<b>c</b>, NMP, 70 °C; (b) 1 M LiOH, THF, MeOH; (c) <i>i</i>-BuCOCl, Et<sub>3</sub>N, <b>23a</b> or <b>23b</b>, LiHMDS; (d) HCl/dioxanes; (e) corresponding alkyl chloroformate, Et<sub>3</sub>N, THF, or corresponding acid, TBTU or HATU, Et<sub>3</sub>N, DMF.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-Alkoxy-4-hydroxyquinoline Derivatives <b>23a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400121t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) R2OH, Et<sub>2</sub>O, HCl(g) 0 °C to rt; (b) R2OH, 40 °C, 4 h; (c) Ph<sub>2</sub>O, 230 °C, 8–10 min.</p></p></figure><div class="NLM_p">The impact of the 2-alkoxyquinoline substitution (compounds <b>2</b>–<b>4</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) on potency against D168V is modest (within 2-fold), but a greater shift in potency against R155K is observed (entries 1–3). Small C-2 substitutions provided improved potency but resulted in a somewhat lower permeability and a considerably lower metabolic stability. In contrast, the size of the N-terminal carbamate (compounds <b>3</b>, <b>5</b>, and <b>6</b>) plays a significant role on the potency against D168V in gt 1b, whereas no impact is observed on R155K gt 1a potency. Primary alkyl carbamates <b>6</b> provided improved potency compared to bulkier carbamates <b>3</b> and <b>5</b>. In correlation with the binding mode of the inhibitor,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> the C-2 quinoline modifications have a more significant impact on the potency against the R155K variant, while N-terminal carbamate modifications mostly affect the potency against D168V, and the effect is more pronounced. Primary alkyl carbamates were then compared to amide groups (entries <b>6</b> and <b>7</b>). The primary butyrylamide <b>7</b> provides similar potency to the corresponding carbamate but suffered from a decreased permeability. As was the case with carbamates, the introduction of bulkier alkyl substitutions was in general not well tolerated and only amides with small groups were tolerated (results not shown). Among the best amides identified, compound <b>8</b> incorporating the 1<i>H</i>-3-pyrazole stood out for its improved metabolic stability but lacked permeability. Throughout this exercise, addressing potency against the R155K gt 1a mutation proved to be more challenging than for D168V gt 1b.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Summary of Preliminary SAR at the C-2 Quinoline and N-Terminal Capping Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0004.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0005.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">The 1<i>H</i>-3-pyrazole amide capping group was then combined with the bulkier isopropyloxy C-2 quinoline substitution in an effort to improve on permeability (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, compound <b>9</b>). In addtition to an improved metabolic stability, an interesting improvement in potency was observed for R155K gt 1a, providing the first inhibitor with single-digit nanomolar potency against both resistance variants. Compound <b>9</b> demonstrated desirable potency and metabolic stability, but permeability remained to be improved. A wide range of small heterocycles were then explored and were found to provide single-digit nanomolar potency against mutant D168V in gt 1b. We first identified the 5-methyl-2-thiophene amide <b>10</b>, which provided 3-fold improvements in potency against the mutants and much higher permeability. The presence of a methyl group in a 1,3-substitution pattern with regard to the amide carbonyl proved to be beneficial for potency. We then further screened small five-membered ring heterocycles to identify the optimal heterocycle, regioisomer, and substitution pattern (compounds <b>11</b>–<b>16</b>). The key methyl group could be attached to either carbon or nitrogen, but a 1,2-substitution pattern and larger heterocycles were on average not well tolerated (results not shown). The position of the heteroatom in the ring also played a crucial role for potency. Replacement of the thiophene moiety by the different thiazole regioisomers <b>11</b>–<b>13</b> while keeping the 1,3-methyl to amide relationship resulted in a 5- to 25-fold loss in potency against both resistance variants. However, the N-methylation of pyrazole <b>9</b> to install the crucial 1,3-methyl amide substitution resulted in compound <b>14</b>, which showed a superior potency profile. As with the thiazoles, a significant loss in potency was observed with the alternative pyrazole amide regioisomer <b>15</b>. Overall, a strong impact of heteroatom positioning on potency is observed. This can be partially rationalized from the crystal structure of compound <b>18</b> bound to the mutant proteases<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> in which the C4-H of N-terminal methylpyrazole forms a CH···O interaction with the backbone oxygen of Ala-157. Heterocycles with acidic C4 hydrogen have the strongest interaction. The best heterocycles identified from this exercise were the 1<i>N</i>-methyl-3-pyrazole and the 2-methyl-3-triazole, leading respectively to compounds <b>14</b> and <b>16</b>. These two inhibitors with similar profiles met our desired potency and metabolic stability criteria, but permeability needed improvement.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of Potency against D168V gt <b>1b</b> and R155K gt <b>1a</b> (Compounds <b>11</b>–<b>23</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0006.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0007.gif" alt="" id="fx5" /></img><div></div></div><div class="NLM_p">Our strategy to improve on permeability was to slightly increase lipophilicity on the <i>N</i>-alkyl substituent of the heterocyclic capping group or at the sulfonamide moiety. We observed that pyrazole capping groups with perfluorinated ethyl chains, as exemplified by compounds <b>17</b> and <b>18</b>, provided a slight improvement in permeability while retaining similar potency profile. Interestingly, these modifications appreciably improved metabolic stability without changes in the CYP 450 inhibition profile. For the sulfonamide substitution, very steep SAR was found and only the cyclopropyl and α-methylcyclopropyl substitutions were tolerated for potency. The addition of an α-methyl substitution to the cyclopropylsulfonamide is well tolerated in terms of potency but resulted in a slightly decreased metabolic stability. However, it has a very beneficial effect on the permeability of these inhibitors. For the <i>N</i>-methyl pyrazole <b>19</b> and the <i>N</i>-methyltriazole <b>20</b>, this resulted in a substantial gain in permeability that was coupled with a 3-fold gain in potency against both mutants.</div><div class="NLM_p">Overall, compounds matching the desired potency criteria were identified and could be divided into two groups. On one hand, fluorinated alkyl heterocyclic analogues <b>17</b> and <b>18</b> demonstrated improved metabolic stability but moderate permeability, whereas α-methylcyclopropylsulfonamide analogues <b>19</b> and <b>20</b> showed higher permeability but moderate metabolic stability. In order to differentiate between the selected compounds and further profile the best analogue, pharmacokinetic studies in rats were performed (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compound <b>18</b> demonstrated higher clearance and lower bioavailability compared to the other three compounds. Compounds <b>17</b>, <b>19</b>, and <b>20</b> showed similar plasma exposure, clearance, and bioavailability.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Profile of Compounds <b>17</b>–<b>20</b> in Rat<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">oral</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">iv</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char=".">RLM <i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (μM·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">[liver], 8 h (μM)</th><th class="colsep0 rowsep0" align="center" char=".">liver <i>K</i><sub>p</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">169</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">360</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">190</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">323</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">138</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">0.97</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">>1500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">107</td><td class="colsep0 rowsep0" align="char" char=".">0.87</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char=".">>1500</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">10 mg/kg po (1% MP, 0.3% Tween-80, and Methocel 0.5%); 4 mg/kg iv (70% PEG-400 and 30% water).</p></div></div></div><div class="NLM_p last">In an evaluation of the pharmacokinetics for this class of inhibitors, a particular focus was placed on the concentration of the inhibitor in the liver, the predominant site of viral replication.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> It was previously reported that clinical efficacy of HCV antivirals was better predicted using the liver-corrected inhibitory quotient (LCIQ, <i>K</i><sub>p</sub>*<i>C</i><sub>min</sub>/EC<sub>50</sub>),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Of the four inhibitors in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, compounds <b>19</b> and <b>20</b> were found to have significantly greater <i>K</i><sub>p</sub>, and thus, these emerged as the preferred compounds from this lead optimization project.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46127" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46127" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, starting from compound <b>1</b>, a macrocyclic acylsulfonamide, we designed inhibitors with improved potency against the key resistant mutations D168V gt 1b and R155K gt 1a. This series of inhibitors must have the 2-alkoxyquinoline at P2, the macrocyclic ring, and the acylsulfonamide to have adequate potency against the key resistant mutations. Acyclic inhibitors containing the same features are much less potent against these variants as are the corresponding macrocyclic carboxylic acids. The modulation of the capping group proved to be essential to achieve single-digit nanomolar potency against the resistance variants. During our optimization of the ADME properties, compounds with higher permeability were identified and selected for further profiling in rats. On the basis of their improved potency and overall profile, including high liver partition, compounds <b>19</b> and <b>20</b> were identified as suitable follow-ups for compound <b>1</b>. Compound <b>19</b> was further profiled against other genotypes and resistance studies were performed. The X-ray structures of compound <b>19</b> in complex with variants were also studied.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> We believe that HCV protease inhibitors displaying superior potency against clinically relevant variants, such as compound <b>19</b>, in combination with other direct-acting antivirals will lead to further improvements in therapy for HCV patients.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40870" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General</h3><div class="NLM_p last">All commercially obtained solvents and reagents were used as received without further purification. All reactions were carried out under an atmosphere of argon. Temperatures are given in °C. Solution percentages express a weight to volume relationship, and solution ratios express a volume to volume relationship, unless stated otherwise. NMR spectra were recorded on a Bruker Avance II (400 MHz for <sup>1</sup>HNMR) spectrometer and were referenced to either DMSO-<i>d</i><sub>6</sub> (2.50 ppm) or CDCl<sub>3</sub> (7.27 ppm). Mass spectra were obtained from a Waters Acquity SQD/TQD instrument using electrospray as ionization mode. Purification of crude material was performed either by flash column chromatography or by using a CombiFlash Rf Teledyne ISCO using RediSep silica or SilicaSep columns according to preprogrammed gradient and flow rate separation conditions in EtOAc/hexane or MeOH/DCM. The final compounds were purified either by column chromatography to yield the neutral compound or by preparative HPLC in a Waters 2767 sample manager with pump 2545, column fluidics organizer (SFO), PDA detector 2996 or mass detector 3100, and Mass Lynx 4.1 using either a Sunfire prep C18 OBD column, 19 mm × 50 mm, 5 μm and a linear gradient program of MeCN/water (0.1%TFA), or a XBridge prep C18 OBD column, 19 mm × 50 mm and a linear gradient program of water (10 nM ammonium bicarbonate, pH 10) and MeOH. Fractions were analyzed by analytical HPLC, and the pure fractions were combined, concentrated, frozen, and lyophilized to yield the desired compound as the trifluoroacetate salt in the case where TFA is used as buffer. The lyophilized TFA salt was dissolved in water, and either 2 or 10 M NaOH was added dropwise until a pH of 14 was maintained. The pH was readjusted to 7 with 2 M HCl and the neutral product extracted into EtOAc. The combined extracts were washed with water (2×) and brine (1×), dried over MgSO<sub>4</sub>, filtered, and evaporated to dryness. The obtained solid was dissolved in acetonitrile/water, frozen, and relyophilized to provide the neutral product. The neutral inhibitor HPLC purity was measured by using a Waters Alliance 2695 separation module with a Waters 2487 dual λ absorbance detector. A Sunfire C18, 4.6 mm × 30 mm, 3.5 μm column was used. Linear gradient at 220 and 254 nm was as follows: 5–100% B; solvent A, 0.1% TFA/H<sub>2</sub>O; solvent B, 0.1% TFA/MeCN. All compounds tested in vitro were determined to be of >95% purity by HPLC.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cell-Based Replicon Assay</h3><div class="NLM_p last">The bicistronic luciferase reporter replicon, encoding the Con1 genotype 1b or H77 1a NS2-NS5B coding region, as well as resistant variants of these, and the experimental procedures for measuring EC<sub>50</sub> values have been described elsewhere.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Briefly, compounds were incubated with cells for 72 h, and the relative levels of luciferase present were determined using the Bright-Glo luciferase substrate (Promega) on a Packard Topcount instrument, and EC<sub>50</sub> values were determined by the nonlinear regression.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vitro ADME Measurements</h3><div class="NLM_p last">Compound stability in human and rat liver microsomes and permeability in Caco-2 cells were evaluated as previously described.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacokinetics</h3><div class="NLM_p last">Pharmacokinetic studies were performed as previously described,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> an oral vehicle consisting of 1% <i>N</i>-methyl-2-pyrrolidone, 0.5% Methocel, and 0.3% Tween-80 and an iv vehicle consisting of 70% PEG-400/30%.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of 4-Hydroxy-7-methoxy-8-methyl-2-isopropoxyquinoline <b>22a</b></h3><div class="NLM_p last">A solution of ethyl cyanoacetate (120 g, 1.06 mol) and isopropanol (70.1 g, 1.16 mol, 1.10 equiv) in anhydrous diethyl ether (1.00 L) was cooled to 0 °C. This solution was purged with HCl gas for 45 min, and then the reaction mixture was warmed to ambient temperature and stirred for 20 h. The solvent was removed in vacuo. The residue was triturated with hexanes, collected by filtration, and dried in vacuo to yield imidate hydrochloride (81 g, 34% yield). To this intermediate (81.0g, 386 mmol) were added 3-methoxy-2-methylaniline (53.0 g, 386 mmol) and isopropanol (800 mL). This mixture was stirred at 40 °C for 3.5 h. The solvent was removed in vacuo, and the remaining residue was dissolved in EtOAc (1.5 L) and washed with brine (500 mL). The organic phase was dried over anhydrous sodium sulfate and concentrated to give compound <b>27</b> (R2 = isopropyl) (128 g) which was used in the next step without further purification. In a 1 L round-bottom flask, <b>27</b> (128 g) was dissolved in diphenyl ether (600 mL), and this mixture was quickly heated (heating mantle) to 230 °C. The temperature was kept between 230 and 245 °C for 8 min. The reaction mixture was then cooled to room temperature, passed through a pad of silica gel (∼1 kg), and washed with hexanes to remove the diphenyl ether. The column was then eluted with a 20–80% EtOAc in hexanes to afford <b>22a</b> (40 g, 42% yield for two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 11.07 (s, 1H), 7.84 (d, 1H, <i>J</i> = 9.2 Hz), 7.14 (d, 1H, <i>J</i> = 9.2 Hz), 6.04 (s, 1H), 5.44 (S, 1H, <i>J</i> = 6.3 Hz), 3.89 (s, 3H), 2.41 (s, 3H), 1.34 (d, 6H, <i>J</i> = 6.3 Hz). FIA MS (electrospray): 246.2 (M – H)<sup>−</sup>, 248.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthesis of Compound <b>2</b></h3><div class="NLM_p"><i>Step 1.</i> Brosylate <b>21</b> (for synthesis see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) (10.0 g, 14.3 mmol) and hydroxyquinoline <b>22a</b> (3.90 g, 15.8 mmol) were dissolved in NMP (150 mL). Cs<sub>2</sub>CO<sub>3</sub> (9.33 g, 28.6 mmol) was added, and the mixture was heated to 70 °C for 8 h. The solution was cooled to room temperature and stirred an additional 8 h. The mixture was diluted with EtOAc and washed with 3 × H<sub>2</sub>O, 2 × NaHCO<sub>3</sub> (sat.), 1 × 1.0 M NaOH, 2 × H2O, and 1 × brine. The organics were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The material was purified by flash chromatography using 30–40% EtOAc/hexanes as the eluent.</div><div class="NLM_p"><i>Step 2.</i> The product containing fractions were combined and concentrated in vacuo to give a white solid (5.94 g, 59%). The solid (5.94 g, 8.38 mmol) was dissolved in THF/MeOH (2/1, 120 mL), and 1 M NaOH (67.0 mL, 67.0 mmol) was added. The reaction mixture was stirred overnight at room temperature. The reaction mixture was concentrated to dryness and the residue taken up in EtOAc/H<sub>2</sub>O. The two phase mixture was acidified to pH ≈ 5 with 10% citric acid. The aqueous phase was extracted with 3 × EtOAc, and the combined organics were washed with 3 × H<sub>2</sub>O and 1 × brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give the corresponding acid (5.90 g, 100%) which was used without further purification.</div><div class="NLM_p"><i>Step 3.</i> The acid was dissolved in DCM (55 mL). Triethylamine (3.85 mL, 27.7 mmol) was added, and the solution was cooled to 0 °C in an ice bath. Isobutyl chloroformate (1.63 mL, 12.6 mmol) was added dropwise, and the mixture was stirred at 0 °C for 1 h and then allowed to warm slowly to room temperature and stirred overnight. The mixture was concentrated in vacuo. The residue was taken up in THF/Et<sub>2</sub>O (1:1, 100 mL), and the mixture was filtered through Celite to remove the salts. The mother liquor was concentrated to dryness to provide azalactone (5.67 g, 100%), which was used as such without further purification.</div><div class="NLM_p last"><i>Step 4.</i> Sulfonamide <b>23a</b> (922 mg, 7.61 mmol, 2.60 equiv) was dissolved in THF (25 mL) and cooled to −20 °C. LiHMDS (1.0 M solution in THF, 6.24 mL, 6.24 mmol, 2.14 equiv) was added all at once. The mixture was stirred at −20 °C for 5 min and then allowed to warm to room temperature for 20 min. The mixture was then recooled to −20 °C. The azalactone from above (1.97 g, 2.92 mmol) was dissolved in THF (20 mL) and added dropwise over 1 h to the sulfonamide anion solution. After the addition was completed, the mixture was allowed to warm to room temperature and the solution stirred overnight. Glacial HOAc (350 μL) was added, and the reaction mixture was concentrated to dryness. The material was purified by flash chromatography using 25–55% EtOAc/hexanes as the eluent. The pure fractions were combined and concentrated in vacuo to provide <b>1</b> as a white solid (1.75 g, 75%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 10.13 (s, 1H), 7.84 (d, <i>J</i> = 9.19 Hz, 1H), 6.91–7.00 (m, 1H), 6.61 (br s, 1H), 5.75 (q, <i>J</i> = 8.80 Hz, 1H), 5.60 (spt, <i>J</i> = 6.19 Hz, 1H), 5.25 (br s, 1H), 5.02 (t, <i>J</i> = 9.39 Hz, 2H), 4.51–4.69 (m, 2H), 4.27–4.39 (m, 1H), 3.97–4.04 (m, 1H), 3.94 (s, 3H), 2.88–2.96 (m, 1H), 2.54 (s, 6H), 2.27–2.36 (m, 1H), 1.78–2.00 (m, 3H), 1.31–1.61 (m, 28H). FIA MS (electrospray): 798.5 (M + H)<sup>+</sup>.</div></div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Intermediate <b>24</b></h3><div class="NLM_p last"><b>24</b> was prepared analogously to compound <b>1</b> by performing the last step with sulfonamide <b>23b</b> instead of sulfonamide <b>23a</b>. Sulfonamide <b>23b</b> (2.40 g, 25.1 mmol) was dissolved in THF (100 mL) and cooled to −20 °C. LiHMDS (1.0 M solution in THF, 21.8 mL, 21.8 mmol) was added all at once. The mixture was stirred at −20 °C for 5 min and then allowed to warm to room temperature for 20 min. The mixture was then recooled to −20 °C. The azalactone from above (5.67 g, 8.38 mmol) was dissolved in THF (40 mL) and added dropwise over 1 h to the sulfonamide anion solution. After the addition was completed, the mixture was allowed to warm to room temperature and the solution stirred overnight. Glacial HOAc (2.0 mL) was added, and the reaction mixture was concentrated to dryness. The material was purified by flash chromatography using 25–55% EtOAc/hexanes as the eluent. The pure fractions were combined and concentrated in vacuo to provide <b>23</b> as a white solid (6.11 g, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.03 (br s, 1H), 7.84 (d, <i>J</i> = 9.00 Hz, 1H), 6.91–7.02 (m, 1H), 6.75 (br s, 1H), 6.02 (s, 1H), 5.69–5.79 (m, 1H), 5.60 (spt, <i>J</i> = 6.23 Hz, 1H), 5.21–5.34 (m, 1H), 4.99–5.13 (m, 2H), 4.54–4.69 (m, 2H), 4.34 (t, <i>J</i> = 7.83 Hz, 1H), 3.97–4.05 (m, 1H), 3.94 (s, 3H), 2.56–2.76 (m, 2H), 2.25–2.35 (m, 1H), 2.12 (s, 3H), 2.07 (s, 3H), 1.75–2.00 (m, 4H), 1.25–1.68 (m, 27H). FIA MS (electrospray): 812.6 (M + H)<sup>+</sup>.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Compound <b>6</b></h3><div class="NLM_p last">Boc protected macrocyclic amine <b>2</b> (40 mg, 0.051 mmol) was charged in a vial with a 4 N solution of HCl in dioxane (3 mL). Solution was stirred at room temperature for 1 h, after which the solution was evaporated to dryness to provide the amine hydrochloride which was used as such. 1-propyl chloroformate (15 mg; 0.077 mmol, 1.2 equiv) was dissolved in THF (3.0 mL), TEA (28 μL; 0.20 mmol, 4.0 equiv) and the amine hydrochloride were added. The reaction was stirred at room temperature overnight. The resulting solution was filtered through a Millex filter and purified by preparative HPLC (X-Bridge column, 10 nM Ammonium Bicarbonate pH 10: MeOH). The pure fractions were combined, concentrated, frozen and lyophilized to provide compound <b>6</b> (24 mg; 61%). FIA MS. (electrospray) for C38H51N5O10S: 770.4 (M + H)<sup>+</sup> . Reverse phase HPLC Homogeneity @ 220 nm (0.1% TFA; CH<sub>3</sub>CN: H<sub>2</sub>0): 98.5%, RT = 5.98 min. <sup>1</sup>H NMR (400 MHz,DMSO-d6): δ = 11.06 (s, 1H), 8.80 (s, 1H), 7.88 (d, 1H, <i>J</i> = 9.0 Hz), 7.43 (d, 1H, <i>J</i> = 6.6 Hz), 7.08 (d, 1H, <i>J</i> = 9.0 Hz), 6.35 (s, 1H), 5.61 (m, 1H), 5.42 (s, 1H), 5.10 (t, 1H, <i>J</i> =  9.8 Hz), 4.50–4.40(m, 4H), 4.35 (m, 1H), 3.71 (t, 1H, <i>J</i> =  6.9 Hz), 2.92–2.87 (m, 1H), 2.68- 2.57 (m, 2H), 2.52–2.28 (m, 10H), 1.76–0.90 (m, 20H), 0.80 (t, 3H, <i>J</i> =  7.4 Hz).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Compound <b>9</b></h3><div class="NLM_p last">Boc protected macrocyclic amine <b>1</b> (100 mg, 0.136 mmol) was charged in a vial with a 4 N solution of HCl in dioxane (3.0 mL). The solution was stirred at room temperature for 1 h, after which the solution was evaporated to dryness to provide the amine hydrochloride which was used as such. 1<i>H</i>-Pyrazole-3-carboxylic acid (18.3 mg, 0.163 mmol, 1.20 equiv) was dissolved in DMF (2.0 mL). Triethylamine (75.9 μL, 0.545 mmol, 4.0 equiv) and HATU (62.1 mg, 0.163 mmol, 1.20 equiv) were added, and the mixture was stirred for 15 min. The Boc deprotected macrocyclic amine hydrochloride was dissolved in DMF (2.0 mL) and added to the acid solution. The mixture was stirred at room temperature overnight. The resulting solution was filtered through a Millex filter and purified by preparative HPLC (X-Bridge column, 10 nM ammonium bicarbonate, pH 10, MeOH). The pure fractions were combined, concentrated, frozen, and lyophilized to provide compound <b>9</b> as a white amorphous solid (107 mg, 99%). FIA MS (electrospray): 790.1 (M – H)<sup>−</sup>, 792.2 (M + H)<sup>+</sup> . Reverse phase HPLC homogeneity at 220 nm (0.1% TFA, CH<sub>3</sub>CN/H<sub>2</sub>O): 100%, <i>t</i><sub>R</sub> = 5.247 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 11.05 (s, 1H), 8.79 (s, 1H), 8.04 (bs, 1H), 7.82 (d, 1H, <i>J</i> = 9 Hz), 7.74 (d, 1H, <i>J</i> = 2.0 Hz), 7.07 (d, 1H, <i>J</i> = 9.0 Hz), 6.71 (s, 1H), 6.37 (s, 1H), 5.61 (dd, 1H, <i>J</i> = 8.3, 18.4 Hz), 5.49 (p, 1H, <i>J</i> =  5.8 Hz), 5.45 (bs, 1H), 5.14 (dd, 2H, <i>J</i> =  9, 10.2 Hz), 4.62–4.54 (m, 2H), 4.34 (dd, 1H, <i>J</i> =  7.0, 9.8 Hz), 4.02 (dd, 1H, <i>J</i> =  3.5, 11.3 Hz), 3.87 (s, 3H), 2.94–2.88 (m, 1H), 2.62- 2.56 (m, 2H), 2.43 (s, 3H), 2.38–2.31 (m, 2H), 2.01–1.92 (m, 1H), 1.80–1.75 (m, 1H), 1.58–1.52 (m, 3H), 1.44–1.36 (m, 10H), 1.31–1.20 (m, 2H), 1.11–0.97 (m, 4H).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Compound <b>19</b></h3><div class="NLM_p last">Intermediate <b>24</b> (2.55 g, 3.14 mmol) was charged in a vial. Then a 4 N solution of HCl in dioxane (40.0 mL, 160 mmol) was added. The solution was stirred at room temperature for 2 h, after which a precipitate had formed. The solution was evaporated to dryness to give the amine hydrochloride. 1-Methyl-1<i>H</i>-pyrazole 4-carboxylic acid (475 mg, 3.77 mmol, 1.20 equiv) was dissolved in DMF (10 mL). Then triethylamine (2.19 mL, 15.7 mmol, 5.0 equiv) was added followed by TBTU (1.43 g, 3.77 mmol, 1.20 equiv). The solution was stirred for 15 min, after which the amine hydrochloride was added in DMF (10 mL) and the solution was stirred at room temperature for 16 h. Work up was the following: Water (25 mL) was added. The organic layer was extracted with EtOAc (3 × 50 mL) and dried over MgSO<sub>4</sub>. The solvent was evaporated. The residue was purified on CombiFlash (25–70% EtOAc/hexane). The pure fractions were combined, concentrated, frozen, and lyophilized to provide compound <b>19</b> (1.90 g, 74%). FIA MS (electrospray): 820 (M + H)<sup>+</sup>. Reverse phase HPLC homogeneity at 220 nm (0.1% TFA, CH<sub>3</sub>CN/H<sub>2</sub>O): 99%. <sup>1</sup>H NMR (400 MHz,DMSO-<i>d</i><sub>6</sub>): δ = 10.83 (s, 1H), 8.93 (s, 1H), 7.83 (d, 1H, <i>J</i> = 8.8 Hz), 7.79 (d, 1H, <i>J</i> = 7.0 Hz), 7.77 (d, 1H, <i>J</i> = 2.1 Hz), 7.08 (d, 1H, <i>J</i> = 9.0 Hz), 6.60 (d, 1H, <i>J</i> = 2.3 Hz), 6.37 (s, 1H), 5.66–5.58 (m, 1H), 5.62 (S, 1H <i>J</i> = 6.2 Hz), 5.47–5.44 (m, 1H), 5.07 (dd, 1H, <i>J</i> = 9.5, 9.2 Hz), 4.64–4.54 (m, 1H) 4.52 (d, 1H, <i>J</i> = 11.6 Hz), 4.40 (dd, 1H, <i>J</i> = 9.7, 7.1 Hz), 4.02 (dd, 1H, <i>J</i> = 11.8, 3.5 Hz), 3.89 (s, 3H), 3.88 (s, 3H), 2.66–2.57 (m, 1H), 2.51 (s, 3H), 2.43 (s, 3H), 2.38–2.29 (m, 2H), 2.02–1.90 (m, 1H), 1.88–1.77 (m, 1H), 1.58 (dd, 1H, <i>J</i> = 8.2, 5.1 Hz), 1.52 (dd, 1H, <i>J</i> = 9.3, 5.2 Hz), 1.45–1.35 (m, 12H), 1.34–1.20 (m, 4H), 0.93–0.84 (m, 2H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of 2-Methyl-2<i>H</i>-1,2,3-triazole-4-carboxylic Acid</h3><div class="NLM_p"><i>Step 1.</i> Methyl cyanoformate (1.00 g, 11.7 mmol) was charged in a flask and dissolved in THF (40.0 mL). Then a 0.6 M diazomethane solution in Et<sub>2</sub>O (58.8 mL, 35.3 mmol, 3.00 equiv) was added. This solution was stirred at room temperature for 16 h. Water (40 mL) and EtOAc (40 mL) were added, and then the layers were separated. The solvent was evaporated and purification was performed on Combiflash (20–100% hexane) to provide the 3,4-regioisomer (654 mg, 39%) and the desired 2,4-regioisomer (434 mg, 26%) as a clear yellow oil. <sup>1</sup>H NMR (400 MHz,CDCl<sub>3</sub>): δ 8.05 (s, 1H), 4.28 (s, 3H) 3.96 (s, 3H). FIA MS (electrospray): 142.2 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Step 2. 2-Methyl-2<i>H</i>-1,2,3-triazole-4-carboxylic acid methyl ester (263 mg, 1.86 mmol) was charged in a round-bottom flask. Then a mixture containing THF (15.0 mL), 1 M solution NaOH (9.30 mL, 9.30 mmol, 5.0 equiv), and MeOH (5.00 mL) was added. The solution was stirred at room temperature. After 4 h, 1 N HCl was added (10.0 mL) and the solvent was evaporated. EtOAc was added, and layers were separated. Solvent was evaporated. 2-Methyl-2<i>H</i>-1,2,3-triazole 4-carboxylic acid was obtained as a white solid (215 mg, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.17 (s, 1H), 4.22 (s, 3H). FIA MS (electrospray): 128.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Compound <b>20</b></h3><div class="NLM_p last">Boc protected amine <b>24</b> (90 mg, 0.12 mmol) was dissolved in DCM (4.0 mL), and a commercial solution of 4 N HCl in dioxane (4.0 mL, 4.0 mmol, 33 equiv) was added. This mixture was stirred at room temperature for 60 min and then concentrated under reduced pressure to afford a residue corresponding to the unprotected amine. The crude intermediate was dissolved in DMF (1.5 mL) along with TEA (81 μL, 0.58 mmol, 5.0 equiv), 2-methyl-2<i>H</i>-1,2,3-triazole 4-carboxylic acid (18 mg, 0.14 mmol, 1.2 equiv), and TBTU (53 mg, 0.14 mmol, 1.2 equiv). The solution was stirred at room temperature for 16 h. The crude mixture was filtered with a Millex filter and purified directly by preparative HPLC. The appropriate fractions were combined, frozen, and lyophilized to give compound <b>20</b> as a white lyophilized solid (37 mg, 39%). <sup>1</sup>H NMR (400 MHz,DMSO-<i>d</i><sub>6</sub>): δ 10.80 (s, 1H), 8.92 (s, 1H), 8.07 (s, 1H), 8.35 (d, 1H, <i>J</i> = 6.7 Hz), 7.85 (d, 1H, <i>J</i> = 8.8 Hz), 7.10 (d, 1H, <i>J</i> = 8.8 Hz), 6.35 (s, 1H), 5.67–5.59 (m 1H), 5.53–5.43 (m, 2H), 5.10–5.03 (m, 1H), 4.62–4.52 (m, 2H), 4.45–4.39 (m, 1H), 4.20 (s, 3H), 4.06–3.98 (m, 1H), 3.89 (s, 3H), 2.69–2.66 (m, 1H), 2.44 (s, 3H), 2.40–2.31 (m, 2H), 2.06–1.94 (m, 1H), 1.89–1.76 (m, 1H), 1.62–1.49 (m, 2H), 1.47–1.35 (m, 14H), 1.34–1.20 (m, 5H), 0.94–0.83 (m, 2H). FIA MS (electrospray): 821.5 (M + H)<sup>+</sup>; 819.3 (M – H)<sup>−</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23"><a href="/doi/suppl/10.1021/jm400121t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed synthesis of macrocycle <b>21</b>, quinolines <b>22b</b>,<b>c</b>, carbamates <b>2</b>–<b>6</b>, and amides <b>7</b>–<b>20</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400121t/suppl_file/jm400121t_si_002.pdf">jm400121t_si_002.pdf (343.04 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400121t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoît Moreau</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4517001602202b203724296b29243305272a202d372c2b222037682c2b2220292d202c286b262a28"><span class="__cf_email__" data-cfemail="5406110713313a312635387a38352214363b313c263d3a333126793d3a3331383c313d397a373b39">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff A. O’Meara</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josée Bordeleau</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Garneau</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cedrickx Godbout</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vida Gorys</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mélissa Leblanc</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisia Villemure</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter W. White</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Montse Llinàs-Brunet</span> - <span class="hlFld-Affiliation affiliation">†Department of Medicinal Chemistry and ‡Department of Biological
Sciences, Research and Development, Boehringer
Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval,
Quebec H7S 2G5, Canada</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d39e1490-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors express their gratitude to the biology, analytical, and structural research department members who contributed to the generation of the data. The authors also thank Drs. Richard Bethell and Michael Cordingley for their guidance and support during this work.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i25" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i25"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26"> Abbreviations Used</h2><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">administration, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P 450</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DAA</td><td class="NLM_def"><p class="first last">direct acting antiviral</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">CDCl<sub>3</sub></td><td class="NLM_def"><p class="first last">deuterated chloroform</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">LCIQ</td><td class="NLM_def"><p class="first last">liver-corrected inhibitory quotient</p></td></tr><tr><td class="NLM_term">LiHMDS</td><td class="NLM_def"><p class="first last">lithium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">MES</td><td class="NLM_def"><p class="first last">2-(<i>N</i>-morpholino)ethanesulfonic acid</p></td></tr><tr><td class="NLM_term">SVR</td><td class="NLM_def"><p class="first last">sustained virological response</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last">tris(2-carboxyethyl)phosphine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">Tris</td><td class="NLM_def"><p class="first last">tris(hydroxymethyl)aminomethane</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0lhScR4SFvKDxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lavanchy, D.</span><span> </span><span class="NLM_article-title">The global burden of hepatitis C</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=74-81&author=D.+Lavanchy&title=The+global+burden+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavanchy%26aufirst%3DD.%26atitle%3DThe%2520global%2520burden%2520of%2520hepatitis%2520C%26jtitle%3DLiver%2520Int.%26date%3D2009%26volume%3D29%26spage%3D74%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forns, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronlein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G. G.</span><span> </span><span class="NLM_article-title">Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1347-1355&author=H.+Hinrichsenauthor=Y.+Benhamouauthor=H.+Wedemeyerauthor=M.+Reiserauthor=R.+E.+Sentjensauthor=J.+L.+Callejaauthor=X.+Fornsauthor=A.+Erhardtauthor=J.+Cronleinauthor=R.+L.+Chavesauthor=C.+L.+Yongauthor=G.+Nehmizauthor=G.+G.+Steinmann&title=Short-term+antiviral+efficacy+of+BILN+2061%2C+a+hepatitis+C+virus+serine+protease+inhibitor%2C+in+hepatitis+C+genotype+1+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DReiser%26aufirst%3DM.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DForns%26aufirst%3DX.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DCronlein%26aufirst%3DJ.%26aulast%3DChaves%26aufirst%3DR.%2BL.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DSteinmann%26aufirst%3DG.%2BG.%26atitle%3DShort-term%2520antiviral%2520efficacy%2520of%2520BILN%25202061%252C%2520a%2520hepatitis%2520C%2520virus%2520serine%2520protease%2520inhibitor%252C%2520in%2520hepatitis%2520C%2520genotype%25201%2520patients%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.+P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.%2BP.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Poordad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boparai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNubile, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sniukiene, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronowicki, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SPRINT-2 Investigators.</span><span> </span><span class="NLM_article-title">Boceprevir for untreated chronic HCV genotype 1 infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1056%2FNEJMoa1010494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=21449783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Chtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1195-1206&author=F.+Poordadauthor=J.+McConeauthor=B.+R.+Baconauthor=S.+Brunoauthor=M.+P.+Mannsauthor=M.+S.+Sulkowskiauthor=I.+M.+Jacobsonauthor=K.+R.+Reddyauthor=Z.+D.+Goodmanauthor=N.+Boparaiauthor=M.+J.+DiNubileauthor=V.+Sniukieneauthor=C.+A.+Brassauthor=J.+K.+Albrechtauthor=J.+P.+Bronowickiauthor=SPRINT-2+Investigators.&title=Boceprevir+for+untreated+chronic+HCV+genotype+1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Boceprevir for untreated chronic HCV genotype 1 infection</span></div><div class="casAuthors">Poordad, Fred; McCone, Jonathan, Jr.; Bacon, Bruce; Bruno, Savino; Manns, Michael P.; Sulkowski, Mark S.; Jacobson, Ira M.; Rajender Reddy, K.; Goodman, Zachary D.; Boparai, Navdeep; DiNubile, Mark J.; Sniukiene, Vilma; Brass, Clifford A.; Albrecht, Janice K.; Bronowicki, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1195-1206</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Peginterferon-ribavirin therapy is the current std. of care for chronic infection with hepatitis C virus (HCV).  The rate of sustained virol. response has been below 50% in cases of HCV genotype 1 infection.  Boceprevir, a potent oral HCV-protease inhibitor, has been evaluated as an addnl. treatment in phase 1 and phase 2 studies.  We conducted a double-blind study in which previously untreated adults with HCV genotype 1 infection were randomly assigned to one of three groups.  In all three groups, peginterferon alfa-2b and ribavirin were administered for 4 wk (the lead- in period).  Subsequently, group 1 (the control group) received placebo plus peginterferon-ribavirin for 44 wk; group 2 received boceprevir plus peginterferon-ribavirin for 24 wk, and those with a detectable HCV RNA level between weeks 8 and 24 received placebo plus peginterferon-ribavirin for an addnl. 20 wk; and group 3 received boceprevir plus peginterferon-ribavirin for 44 wk.  Non-black patients and black patients were enrolled and analyzed sep.  A total of 938 non-black and 159 black patients were treated.  In the non-black cohort, a sustained virol. response was achieved in 125 of the 311 patients (40%) in group 1, in 211 of the 316 patients (67%) in group 2 (P < 0.001), and in 213 of the 311 patients (68%) in group 3 (P < 0.001).  In the black cohort, a sustained virol. response was achieved in 12 of the 52 patients (23%) in group 1, in 22 of the 52 patients (42%) in group 2 (P = 0.04), and in 29 of the 55 patients (53%) in group 3 (P = 0.004).  In group 2, a total of 44% of patients received peginterferon-ribavirin for 28 wk.  Anemia led to dose redns. in 13% of controls and 21% of boceprevir recipients, with discontinuations in 1% and 2%, resp.  The addn. of boceprevir to std. therapy with peginterferon-ribavirin, as compared with std. therapy alone, significantly increased the rates of sustained virol. response in previously untreated adults with chronic HCV genotype 1 infection.  The rates were similar with 24 wk and 44 wk of boceprevir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCdL0rY0lmGrVg90H21EOLACvtfcHk0liOGjKI2DAWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Chtrc%253D&md5=47ea838a941fdf7f9a27350a403e794e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1010494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1010494%26sid%3Dliteratum%253Aachs%26aulast%3DPoordad%26aufirst%3DF.%26aulast%3DMcCone%26aufirst%3DJ.%26aulast%3DBacon%26aufirst%3DB.%2BR.%26aulast%3DBruno%26aufirst%3DS.%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DSulkowski%26aufirst%3DM.%2BS.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DGoodman%26aufirst%3DZ.%2BD.%26aulast%3DBoparai%26aufirst%3DN.%26aulast%3DDiNubile%26aufirst%3DM.%2BJ.%26aulast%3DSniukiene%26aufirst%3DV.%26aulast%3DBrass%26aufirst%3DC.%2BA.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26aulast%3DBronowicki%26aufirst%3DJ.%2BP.%26aulast%3D%26atitle%3DBoceprevir%2520for%2520untreated%2520chronic%2520HCV%2520genotype%25201%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1195%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusheiko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bisceglie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzowej, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferenci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flisiak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzetto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shouval, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankoh, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ADVANCE Study Team.</span><span> </span><span class="NLM_article-title">Telaprevir for previously untreated chronic hepatitis C virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">2405</span><span class="NLM_x">–</span> <span class="NLM_lpage">2416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1056%2FNEJMoa1012912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=21696307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVCku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=2405-2416&author=I.+M.+Jacobsonauthor=J.+G.+McHutchisonauthor=G.+Dusheikoauthor=A.+M.+Di+Bisceglieauthor=K.+R.+Reddyauthor=N.+H.+Bzowejauthor=P.+Marcellinauthor=A.+J.+Muirauthor=P.+Ferenciauthor=R.+Flisiakauthor=J.+Georgeauthor=M.+Rizzettoauthor=D.+Shouvalauthor=R.+Solaauthor=R.+A.+Tergauthor=E.+M.+Yoshidaauthor=N.+Addaauthor=L.+Bengtssonauthor=A.+J.+Sankohauthor=T.+L.+Kiefferauthor=S.+Georgeauthor=R.+S.+Kauffmanauthor=S.+Zeuzemauthor=ADVANCE+Study+Team.&title=Telaprevir+for+previously+untreated+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Telaprevir for previously untreated chronic hepatitis C virus infection</span></div><div class="casAuthors">Jacobson, Ira M.; McHutchison, John G.; Dusheiko, Geoffrey; Di Bisceglie, Adrian M.; Reddy, K. Rajender; Bzowej, Natalie H.; Marcellin, Patrick; Muir, Andrew J.; Ferenci, Peter; Flisiak, Robert; George, Jacob; Rizzetto, Mario; Shouval, Daniel; Sola, Ricard; Terg, Ruben A.; Yoshida, Eric M.; Adda, Nathalie; Bengtsson, Leif; Sankoh, Abdul J.; Kieffer, Tara L.; George, Shelley; Kauffman, Robert S.; Zeuzem, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2405-2416</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with peginterferon-ribavirin, as compared with peginterferon-ribavirin alone, has shown improved efficacy, with potential for shortening the duration of treatment in a majority of patients.  METHODS: In this international, phase 3, randomized, double-blind, placebo-controlled trial, we assigned 1088 patients with HCV genotype 1 infection who had not received previous treatment for the infection to one of three groups: a group receiving telaprevir combined with peginterferon alfa-2a and ribavirin for 12 wk (T12PR group), followed by peginterferon-ribavirin alone for 12 wk if HCV RNA was undetectable at weeks 4 and 12 or for 36 wk if HCV RNA was detectable at either time point; a group receiving telaprevir with peginterferon-ribavirin for 8 wk and placebo with peginterferon-ribavirin for 4 wk (T8PR group), followed by 12 or 36 wk of peginterferon-ribavirin on the basis of the same HCV RNA criteria; or a group receiving placebo with peginterferon-ribavirin for 12 wk, followed by 36 wk of peginterferon-ribavirin (PR group).  The primary end point was the proportion of patients who had undetectable plasma HCV RNA 24 wk after the last planned dose of study treatment (sustained virol. response).  RESULTS: Significantly more patients in the T12PR or T8PR group than in the PR group had a sustained virol. response (75% and 69%, resp., vs. 44%; P < 0.001 for the comparison of the T12PR or T8PR group with the PR group).  A total of 58% of the patients treated with telaprevir were eligible to receive 24 wk of total treatment.  Anemia, gastrointestinal side effects, and skin rashes occurred at a higher incidence among patients receiving telaprevir than among those receiving peginterferon-ribavirin alone.  The overall rate of discontinuation of the treatment regimen owing to adverse events was 10% in the T12PR and T8PR groups and 7% in the PR group.  CONCLUSIONS: Telaprevir with peginterferon-ribavirin, as compared with peginterferon-ribavirin alone, was assocd. with significantly improved rates of sustained virol. response in patients with HCV genotype 1 infection who had not received previous treatment, with only 24 wk of therapy administered in the majority of patients. (Funded by Vertex Pharmaceuticals and Tibotec; ADVANCE ClinicalTrials.gov no., NCT00627926.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcImqLMQ63DLVg90H21EOLACvtfcHk0liOGjKI2DAWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVCku7Y%253D&md5=16aff3164348c2bfe80fc14121eb7b93</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1012912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1012912%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DDusheiko%26aufirst%3DG.%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DBzowej%26aufirst%3DN.%2BH.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DMuir%26aufirst%3DA.%2BJ.%26aulast%3DFerenci%26aufirst%3DP.%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DRizzetto%26aufirst%3DM.%26aulast%3DShouval%26aufirst%3DD.%26aulast%3DSola%26aufirst%3DR.%26aulast%3DTerg%26aufirst%3DR.%2BA.%26aulast%3DYoshida%26aufirst%3DE.%2BM.%26aulast%3DAdda%26aufirst%3DN.%26aulast%3DBengtsson%26aufirst%3DL.%26aulast%3DSankoh%26aufirst%3DA.%2BJ.%26aulast%3DKieffer%26aufirst%3DT.%2BL.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3D%26atitle%3DTelaprevir%2520for%2520previously%2520untreated%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D2405%26epage%3D2416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Preclinical characterization of BI 201335, a C-terminal carbosylic acid inhibitor of the hepatitis C virus NS3-NS4A protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4611</span><span class="NLM_x">–</span> <span class="NLM_lpage">4618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4611-4618&author=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunetauthor=M.+Amadauthor=R.+C.+Bethellauthor=G.+Bolgerauthor=M.+G.+Cordingleyauthor=J.+Duanauthor=M.+Garneauauthor=L.+Lagac%C3%A9author=D.+Thibeaultauthor=G.+Kukolj&title=Preclinical+characterization+of+BI+201335%2C+a+C-terminal+carbosylic+acid+inhibitor+of+the+hepatitis+C+virus+NS3-NS4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DPreclinical%2520characterization%2520of%2520BI%2520201335%252C%2520a%2520C-terminal%2520carbosylic%2520acid%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4611%26epage%3D4618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonacini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boecher, W. O.</span><span> </span><span class="NLM_article-title">Potency, safety and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1016%2Fj.jhep.2010.08.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=21145839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1114-1122&author=M.+P.+Mannsauthor=M.+Bourli%C3%A8reauthor=Y.+Benhamouauthor=S.+Polauthor=M.+Bonaciniauthor=C.+Trepoauthor=D.+Wrightauthor=T.+Bergauthor=J.+L.+Callejaauthor=P.+W.+Whiteauthor=J.+O.+Sternauthor=G.+Steinmannauthor=C.+L.+Yongauthor=G.+Kukoljauthor=J.+Schererauthor=W.+O.+Boecher&title=Potency%2C+safety+and+pharmacokinetics+of+the+NS3%2F4A+protease+inhibitor+BI201335+in+patients+with+chronic+HCV+genotype-1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection</span></div><div class="casAuthors">Manns, Michael P.; Bourliere, Marc; Benhamou, Yves; Pol, Stanislas; Bonacini, Maurizio; Trepo, Christian; Wright, David; Berg, Thomas; Calleja, Jose L.; White, Peter W.; Stern, Jerry O.; Steinmann, Gerhard; Yong, Chan-Loi; Kukolj, George; Scherer, Joe; Boecher, Wulf O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1114-1122</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background & Aims: BI201335 is a highly specific and potent HCV protease inhibitor.  This multiple rising dose trial evaluated antiviral activity and safety in chronic HCV genotype-1 patients.  Methods: Thirty-four treatment-naive patients were randomized to monotherapy with placebo or BI201335 at 20-240 mg once-daily for 14 days, followed by combination with pegylated interferon alfa/ribavirin (PegIFN/RBV) through Day 28.  Nineteen treatment-experienced patients received 48-240 mg BI201335 once-daily with PegIFN/RBV for 28 days.  HCV-RNA was measured with Roche COBAS TaqMan.  Results: In treatment-naive patients, median maximal viral load (VL) redns. during 14-day monotherapy were -3.0, -3.6, -3.7, and -4.2 log10 for the 20, 48, 120, and 240 mg groups.  VL breakthroughs (≥1 log10 from nadir) were seen in most patients on monotherapy and were caused by NS3/4A variants (R155K, D168V) conferring in vitro resistance to BI201335.  Adding PegIFN/RBV at Days 15-28 led to continuous viral load redns. in most patients.  In treatment-experienced patients, treatment with BI201335 and PegIFN/RBV achieved VL <25 IU/mL at Day 28 in 3/6, 4/7, and 5/6 patients in the 48, 120, and 240 mg dose groups.  VL breakthroughs were obsd. during triple combination in only 3/19 patients.  BI201335 was generally well tolerated.  Mild rash or photosensitivity was detected in four patients.  Mild unconjugated hyperbilirubinemia was the only dose-dependent lab. abnormality of BI201335.  BI201335 elimination half-life supports once-daily dosing.  Conclusions: BI201335 combined with PegIFN/RBV was well tolerated and induced strong antiviral responses.  These results support further development of BI201335 in HCV genotype-1 patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBRyXVmCJAfbVg90H21EOLACvtfcHk0lgCcYy2vJve-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVygsr0%253D&md5=b82161fb58cbfd5bef7f0d59ad7b8b78</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2010.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2010.08.040%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DBonacini%26aufirst%3DM.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DStern%26aufirst%3DJ.%2BO.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DScherer%26aufirst%3DJ.%26aulast%3DBoecher%26aufirst%3DW.%2BO.%26atitle%3DPotency%252C%2520safety%2520and%2520pharmacokinetics%2520of%2520the%2520NS3%252F4A%2520protease%2520inhibitor%2520BI201335%2520in%2520patients%2520with%2520chronic%2520HCV%2520genotype-1%2520infection%26jtitle%3DJ.%2520Hepatol.%26date%3D2011%26volume%3D54%26spage%3D1114%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massariol, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spickler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">In vitro resistance profile of the hepatitis C virus NS3 protease inhibitor BI 201335</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=569-572&author=L.+Lagaceauthor=P.+W.+Whiteauthor=C.+Bousquetauthor=N.+Dansereauauthor=F.+Doauthor=M.+Llinas-Brunetauthor=M.+Marquisauthor=M.+J.+Massariolauthor=R.+Mauriceauthor=C.+Spicklerauthor=D.+Thibeaultauthor=I.+Trikiauthor=S.+Zhaoauthor=G.+Kukolj&title=In+vitro+resistance+profile+of+the+hepatitis+C+virus+NS3+protease+inhibitor+BI+201335"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DBousquet%26aufirst%3DC.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DDo%26aufirst%3DF.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DMassariol%26aufirst%3DM.%2BJ.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DSpickler%26aufirst%3DC.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTriki%26aufirst%3DI.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DIn%2520vitro%2520resistance%2520profile%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%2520BI%2520201335%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D569%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbinnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijgen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berke, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehertogh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeiren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K. A.</span><span> </span><span class="NLM_article-title">In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1878</span><span class="NLM_x">–</span> <span class="NLM_lpage">1887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1878-1887&author=O.+Lenzauthor=T.+Verbinnenauthor=T.+I.+Linauthor=L.+Vijgenauthor=M.+D.+Cummingsauthor=J.+Lindbergauthor=J.+M.+Berkeauthor=P.+Dehertoghauthor=E.+Fransenauthor=A.+Scholliersauthor=K.+Vermeirenauthor=T.+Ivensauthor=P.+Raboissonauthor=M.+Edlundauthor=S.+Stormauthor=L.+Vrangauthor=K.+H.+deauthor=G.+C.+Fanningauthor=K.+A.+Simmen&title=In+vitro+resistance+profile+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+TMC435"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DVerbinnen%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DVijgen%26aufirst%3DL.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLindberg%26aufirst%3DJ.%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26aulast%3DDehertogh%26aufirst%3DP.%26aulast%3DFransen%26aufirst%3DE.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DVermeiren%26aufirst%3DK.%26aulast%3DIvens%26aufirst%3DT.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DStorm%26aufirst%3DS.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3Dde%26aufirst%3DK.%2BH.%26aulast%3DFanning%26aufirst%3DG.%2BC.%26aulast%3DSimmen%26aufirst%3DK.%2BA.%26atitle%3DIn%2520vitro%2520resistance%2520profile%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520TMC435%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D1878%26epage%3D1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Welsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span> </span><span class="NLM_article-title">Will interferon-free regimens prevail?</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=1351-1355&author=C.+Welschauthor=S.+Zeuzem&title=Will+interferon-free+regimens+prevail%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DC.%26aulast%3DZeuzem%26aufirst%3DS.%26atitle%3DWill%2520interferon-free%2520regimens%2520prevail%253F%26jtitle%3DGastroenterology%26date%3D2012%26volume%3D142%26spage%3D1351%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">O’meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">Molecular mechanism by which a potent hepatitis C virus NS3-NS4A protease inhibitor overcomes emergence of resistance</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">5673</span><span class="NLM_x">–</span> <span class="NLM_lpage">5681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=5673-5681&author=J.+O%E2%80%99mearaauthor=C.+T.+Lemkeauthor=C.+Godboutauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=B.+Moreauauthor=D.+Thibeaultauthor=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunet&title=Molecular+mechanism+by+which+a+potent+hepatitis+C+virus+NS3-NS4A+protease+inhibitor+overcomes+emergence+of+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599meara%26aufirst%3DJ.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DGodbout%26aufirst%3DC.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DMoreau%26aufirst%3DB.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DMolecular%2520mechanism%2520by%2520which%2520a%2520potent%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520protease%2520inhibitor%2520overcomes%2520emergence%2520of%2520resistance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D5673%26epage%3D5681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Campbell, J. A.; Good, A.</span><span> </span><span class="NLM_article-title">Hepatitis C Tripeptide Inhibitors</span>. WO 2002/060926 A2,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+A.+Campbell&author=A.+Good&title=Hepatitis+C+Tripeptide+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26atitle%3DHepatitis%2520C%2520Tripeptide%2520Inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poliakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiklund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiwarter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2551-2568&author=A.+Johanssonauthor=A.+Poliakovauthor=E.+Akerblomauthor=K.+Wiklundauthor=G.+Lindebergauthor=S.+Winiwarterauthor=U.+H.+Danielsonauthor=B.+Samuelssonauthor=A.+Hallberg&title=Acyl+sulfonamides+as+potent+protease+inhibitors+of+the+hepatitis+C+virus+full-length+NS3+%28protease-helicase%2FNTPase%29%3A+a+comparative+study+of+different+C-terminals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DPoliakov%26aufirst%3DA.%26aulast%3DAkerblom%26aufirst%3DE.%26aulast%3DWiklund%26aufirst%3DK.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DAcyl%2520sulfonamides%2520as%2520potent%2520protease%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520full-length%2520NS3%2520%2528protease-helicase%252FNTPase%2529%253A%2520a%2520comparative%2520study%2520of%2520different%2520C-terminals%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2551%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ronn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A.</span><span> </span><span class="NLM_article-title">Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=544-559&author=R.+Ronnauthor=Y.+A.+Sabnisauthor=T.+Gossasauthor=E.+Akerblomauthor=U.+H.+Danielsonauthor=A.+Hallbergauthor=A.+Johansson&title=Exploration+of+acyl+sulfonamides+as+carboxylic+acid+replacements+in+protease+inhibitors+of+the+hepatitis+C+virus+full-length+NS3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRonn%26aufirst%3DR.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DAkerblom%26aufirst%3DE.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DA.%26atitle%3DExploration%2520of%2520acyl%2520sulfonamides%2520as%2520carboxylic%2520acid%2520replacements%2520in%2520protease%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520full-length%2520NS3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D544%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span> </span><span class="NLM_article-title">Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">11434</span><span class="NLM_x">–</span> <span class="NLM_lpage">11443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1074%2Fjbc.M110.211417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=21270126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslKgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=11434-11443&author=C.+T.+Lemkeauthor=N.+Goudreauauthor=S.+Zhaoauthor=O.+Huckeauthor=D.+Thibeaultauthor=M.+Llinas-Brunetauthor=P.+W.+White&title=Combined+X-ray%2C+NMR%2C+and+kinetic+analyses+reveal+uncommon+binding+characteristics+of+the+hepatitis+C+virus+NS3-NS4A+protease+inhibitor+BI+201335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335</span></div><div class="casAuthors">Lemke, Christopher T.; Goudreau, Nathalie; Zhao, Songping; Hucke, Oliver; Thibeault, Diane; Llinas-Brunet, Montse; White, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">11434-11443</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hepatitis C virus infection, a major cause of liver disease worldwide, is curable, but currently approved therapies have suboptimal efficacy.  Supplementing these therapies with direct-acting antiviral agents has the potential to considerably improve treatment prospects for hepatitis C virus-infected patients.  The crit. role played by the viral NS3 protease makes it an attractive target, and despite its shallow, solvent-exposed active site, several potent NS3 protease inhibitors are currently in the clinic.  BI 201335, which is progressing through Phase IIb trials, contains a unique C-terminal carboxylic acid that binds noncovalently to the active site and a bromo-quinoline substitution on its proline residue that provides significant potency.  In this work we have used stopped flow kinetics, x-ray crystallog., and NMR to characterize these distinctive features.  Key findings include: slow assocn. and dissocn. rates within a single-step binding mechanism; the crit. involvement of water mols. in acid binding; and protein side chain rearrangements, a bromine-oxygen halogen bond, and profound pKa changes within the catalytic triad assocd. with binding of the bromo-quinoline moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkdn8YiZZHALVg90H21EOLACvtfcHk0lj-ycOv8c3PuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslKgsbs%253D&md5=2281c4bbfd76e34934f129fb61dcf926</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.211417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.211417%26sid%3Dliteratum%253Aachs%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26atitle%3DCombined%2520X-ray%252C%2520NMR%252C%2520and%2520kinetic%2520analyses%2520reveal%2520uncommon%2520binding%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520protease%2520inhibitor%2520BI%2520201335%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D11434%26epage%3D11443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Yee, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houpis, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frutos, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Keenan, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitous, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridges, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicola, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samstag, W.</span><span> </span><span class="NLM_article-title">Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesis</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">7133</span><span class="NLM_x">–</span> <span class="NLM_lpage">7145</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo060285j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1KgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=7133-7145&author=N.+K.+Yeeauthor=V.+Farinaauthor=I.+N.+Houpisauthor=N.+Haddadauthor=R.+P.+Frutosauthor=F.+Gallouauthor=X.+J.+Wangauthor=X.+Weiauthor=R.+D.+Simpsonauthor=X.+Fengauthor=V.+Fuchsauthor=Y.+Xuauthor=J.+Tanauthor=L.+Zhangauthor=J.+Xuauthor=L.+L.+Smith-Keenanauthor=J.+Vitousauthor=M.+D.+Ridgesauthor=E.+M.+Spinelliauthor=M.+Johnsonauthor=K.+Donsbachauthor=T.+Nicolaauthor=M.+Brennerauthor=E.+Winterauthor=P.+Kreyeauthor=W.+Samstag&title=Efficient+large-scale+synthesis+of+BILN+2061%2C+a+potent+HCV+protease+inhibitor%2C+by+a+convergent+approach+based+on+ring-closing+metathesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Large-Scale Synthesis of BILN 2061, a Potent HCV Protease Inhibitor, by a Convergent Approach Based on Ring-Closing Metathesis</span></div><div class="casAuthors">Yee, Nathan K.; Farina, Vittorio; Houpis, Ioannis N.; Haddad, Nizar; Frutos, Rogelio P.; Gallou, Fabrice; Wang, Xiao-Jun; Wei, Xudong; Simpson, Robert D.; Feng, Xuwu; Fuchs, Victor; Xu, Yibo; Tan, Jonathan; Zhang, Li; Xu, Jinghua; Smith-Keenan, Lana L.; Vitous, Jana; Ridges, Michael D.; Spinelli, Earl M.; Johnson, Michael; Donsbach, Kai; Nicola, Thomas; Brenner, Michael; Winter, Eric; Kreye, Paul; Samstag, Wendelin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7133-7145</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A multistep scalable synthesis of the clin. important hepatitis C virus (HCV) protease inhibitor BILN 2061 (1) is described.  The synthesis is highly convergent and consists of two amide bond formations, one etherification, and one ring-closing metathesis (RCM) step, using readily available building blocks 2-5.  The optimization of each step is described at length.  The main focus of the paper is the study of the RCM step and the description of the main problems faced when scaling up to pilot scale this highly powerful but very challenging synthetic operation.  Eventually, the RCM reaction was smoothly scaled up to produce >400 kg of cyclized product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf2OnRGfj7hrVg90H21EOLACvtfcHk0lhklrwKfEF-Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1KgsL4%253D&md5=c624c44d7818034d362fc8798cb83d09</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjo060285j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo060285j%26sid%3Dliteratum%253Aachs%26aulast%3DYee%26aufirst%3DN.%2BK.%26aulast%3DFarina%26aufirst%3DV.%26aulast%3DHoupis%26aufirst%3DI.%2BN.%26aulast%3DHaddad%26aufirst%3DN.%26aulast%3DFrutos%26aufirst%3DR.%2BP.%26aulast%3DGallou%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DSimpson%26aufirst%3DR.%2BD.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DFuchs%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DSmith-Keenan%26aufirst%3DL.%2BL.%26aulast%3DVitous%26aufirst%3DJ.%26aulast%3DRidges%26aufirst%3DM.%2BD.%26aulast%3DSpinelli%26aufirst%3DE.%2BM.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DDonsbach%26aufirst%3DK.%26aulast%3DNicola%26aufirst%3DT.%26aulast%3DBrenner%26aufirst%3DM.%26aulast%3DWinter%26aufirst%3DE.%26aulast%3DKreye%26aufirst%3DP.%26aulast%3DSamstag%26aufirst%3DW.%26atitle%3DEfficient%2520large-scale%2520synthesis%2520of%2520BILN%25202061%252C%2520a%2520potent%2520HCV%2520protease%2520inhibitor%252C%2520by%2520a%2520convergent%2520approach%2520based%2520on%2520ring-closing%2520metathesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D7133%26epage%3D7145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P. M.</span><span> </span><span class="NLM_article-title">A facile synthesis of 1-substituted cyclopropylsulfonamides</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=725-728&author=J.+Liauthor=D.+Smithauthor=H.+S.+Wongauthor=J.+A.+Campbellauthor=N.+A.+Meanwellauthor=P.+M.+Scola&title=A+facile+synthesis+of+1-substituted+cyclopropylsulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DScola%26aufirst%3DP.%2BM.%26atitle%3DA%2520facile%2520synthesis%2520of%25201-substituted%2520cyclopropylsulfonamides%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26spage%3D725%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuhart, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomassen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuerborn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kae, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretch, D. R.</span><span> </span><span class="NLM_article-title">Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">2280</span><span class="NLM_x">–</span> <span class="NLM_lpage">2290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1128%2FJVI.80.5.2280-2290.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=16474135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFyhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=2280-2290&author=S.+Palauthor=M.+C.+Shuhartauthor=L.+Thomassenauthor=S.+S.+Emersonauthor=T.+Suauthor=N.+Feuerbornauthor=J.+Kaeauthor=D.+R.+Gretch&title=Intrahepatic+hepatitis+C+virus+replication+correlates+with+chronic+hepatitis+C+disease+severity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo</span></div><div class="casAuthors">Pal, Sampa; Shuhart, Margaret C.; Thomassen, Lisa; Emerson, Scott S.; Su, Tao; Feuerborn, Nathan; Kae, John; Gretch, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2280-2290</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The role of viral factors in the pathogenesis of chronic hepatitis C is unknown.  The objective of the present study was to characterize markers of hepatitis C virus (HCV) infection and replication in liver biopsy specimens obtained from 65 genotype 1-infected subjects, including 31 who were coinfected with human immunodeficiency virus (HIV), and to analyze assocns. between intrahepatic viral markers and hepatitis C disease severity.  The percentages of liver cells harboring HCV genomes (%G) and replicative-intermediate RNAs (%RI) were evaluated using strand-specific in situ hybridization, while HCV core and NS3 antigens were assessed by immunocytochem.  HIV-pos. and HIV-neg. subjects had similar mean grades and stages of liver disease and had similar indexes of HCV infection and replication in liver, even though coinfected subjects had significantly shorter mean disease duration (P = 0.0003).  Multivariate anal. showed that %G was not assocd. with grade or stage of liver disease (P = 0.5 and 0.4, resp.), while %RI was strongly assocd. with liver inflammation (P < 0.001), liver fibrosis (P < 0.001), and serum alanine aminotransferase levels (P = 0.01).  NS3 antigen (but not core) was more frequently detected in HCV RI-pos. vs. RI-neg. specimens (P = 0.028).  These findings demonstrate a link between HCV proliferation and hepatitis C disease severity and suggest similar pathogenic mechanisms in HIV-pos. and HIV-neg. individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkX58TDz-HsbVg90H21EOLACvtfcHk0ljZc2J8-LPTEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFyhtrc%253D&md5=fe2211928db49911b3cde3230a5548ea</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FJVI.80.5.2280-2290.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.80.5.2280-2290.2006%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DS.%26aulast%3DShuhart%26aufirst%3DM.%2BC.%26aulast%3DThomassen%26aufirst%3DL.%26aulast%3DEmerson%26aufirst%3DS.%2BS.%26aulast%3DSu%26aufirst%3DT.%26aulast%3DFeuerborn%26aufirst%3DN.%26aulast%3DKae%26aufirst%3DJ.%26aulast%3DGretch%26aufirst%3DD.%2BR.%26atitle%3DIntrahepatic%2520hepatitis%2520C%2520virus%2520replication%2520correlates%2520with%2520chronic%2520hepatitis%2520C%2520disease%2520severity%2520in%2520vivo%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D2280%26epage%3D2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batonga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montpetit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span> </span><span class="NLM_article-title">The liver partition coefficient-corrected inhibitory quotient and the pharmacokinetic–pharmacodynamic relationship of directly acting anti-hepatitis C virus agents in humans</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5381</span><span class="NLM_x">–</span> <span class="NLM_lpage">5386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5381-5386&author=J.+Duanauthor=G.+Bolgerauthor=M.+Garneauauthor=M.+Amadauthor=J.+Batongaauthor=H.+Montpetitauthor=F.+Otisauthor=M.+Jutrasauthor=N.+Lapeyreauthor=M.+Rheaumeauthor=G.+Kukoljauthor=P.+W.+Whiteauthor=R.+C.+Bethellauthor=M.+G.+Cordingley&title=The+liver+partition+coefficient-corrected+inhibitory+quotient+and+the+pharmacokinetic%E2%80%93pharmacodynamic+relationship+of+directly+acting+anti-hepatitis+C+virus+agents+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DBatonga%26aufirst%3DJ.%26aulast%3DMontpetit%26aufirst%3DH.%26aulast%3DOtis%26aufirst%3DF.%26aulast%3DJutras%26aufirst%3DM.%26aulast%3DLapeyre%26aufirst%3DN.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26atitle%3DThe%2520liver%2520partition%2520coefficient-corrected%2520inhibitory%2520quotient%2520and%2520the%2520pharmacokinetic%25E2%2580%2593pharmacodynamic%2520relationship%2520of%2520directly%2520acting%2520anti-hepatitis%2520C%2520virus%2520agents%2520in%2520humans%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5381%26epage%3D5386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montpetit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span> </span><span class="NLM_article-title">Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=164-172&author=J.+Duanauthor=C.+L.+Yongauthor=M.+Garneauauthor=M.+Amadauthor=G.+Bolgerauthor=M.+J.+Deauthor=H.+Montpetitauthor=F.+Otisauthor=M.+Jutrasauthor=M.+Rheaumeauthor=P.+W.+Whiteauthor=M.+Llinas-Brunetauthor=R.+C.+Bethellauthor=M.+G.+Cordingley&title=Cross-species+absorption%2C+metabolism%2C+distribution+and+pharmacokinetics+of+BI+201335%2C+a+potent+HCV+genotype+1+NS3%2F4A+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DDe%26aufirst%3DM.%2BJ.%26aulast%3DMontpetit%26aufirst%3DH.%26aulast%3DOtis%26aufirst%3DF.%26aulast%3DJutras%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26atitle%3DCross-species%2520absorption%252C%2520metabolism%252C%2520distribution%2520and%2520pharmacokinetics%2520of%2520BI%2520201335%252C%2520a%2520potent%2520HCV%2520genotype%25201%2520NS3%252F4A%2520protease%2520inhibitor%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26spage%3D164%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 24 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ashley N. Matthew, Florian Leidner, Gordon J. Lockbaum, Mina Henes, Jacqueto Zephyr, Shurong Hou, Desaboini Nageswara Rao, Jennifer Timm, Linah N. Rusere, Debra A. Ragland, Janet L. Paulsen, Kristina Prachanronarong, Djade I. Soumana, Ellen A. Nalivaika, Nese Kurt Yilmaz, Akbar Ali, <span class="NLM_string-name hlFld-ContribAuthor">Celia A. Schiffer</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3238-3270. <a href="https://doi.org/10.1021/acs.chemrev.0c00648" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00648%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DDrug%252BDesign%252BStrategies%252Bto%252BAvoid%252BResistance%252Bin%252BDirect-Acting%252BAntivirals%252Band%252BBeyond%26aulast%3DMatthew%26aufirst%3DAshley%2BN.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22062020%26date%3D07012021%26volume%3D121%26issue%3D6%26spage%3D3238%26epage%3D3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashley N.  Matthew</span>, <span class="hlFld-ContribAuthor ">Jacqueto  Zephyr</span>, <span class="hlFld-ContribAuthor ">Caitlin. J.  Hill</span>, <span class="hlFld-ContribAuthor ">Muhammad  Jahangir</span>, <span class="hlFld-ContribAuthor ">Alicia  Newton</span>, <span class="hlFld-ContribAuthor ">Christos J.  Petropoulos</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Nese  Kurt-Yilmaz</span>, <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>, and <span class="hlFld-ContribAuthor ">Akbar  Ali</span>  . </span><span class="cited-content_cbyCitation_article-title">Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5699-5716. <a href="https://doi.org/10.1021/acs.jmedchem.7b00426" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00426%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252BInhibitors%252BIncorporating%252BFlexible%252BP2%252BQuinoxalines%252BTarget%252BDrug%252BResistant%252BViral%252BVariants%26aulast%3DMatthew%26aufirst%3DAshley%2BN.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D16032017%26date%3D19062017%26date%3D13072017%26date%3D08062017%26volume%3D60%26issue%3D13%26spage%3D5699%26epage%3D5716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A. T.  Blaskovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Unusual Amino Acids in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 10807-10836. <a href="https://doi.org/10.1021/acs.jmedchem.6b00319" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnusual%252BAmino%252BAcids%252Bin%252BMedicinal%252BChemistry%26aulast%3DBlaskovich%26aufirst%3DMark%2BA.%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D30092016%26date%3D22122016%26date%3D02092016%26volume%3D59%26issue%3D24%26spage%3D10807%26epage%3D10836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santhosh F.  Neelamkavil</span>, <span class="hlFld-ContribAuthor ">Sony  Agrawal</span>, <span class="hlFld-ContribAuthor ">Thomas  Bara</span>, <span class="hlFld-ContribAuthor ">Chad  Bennett</span>, <span class="hlFld-ContribAuthor ">Sathesh  Bhat</span>, <span class="hlFld-ContribAuthor ">Dipshikha  Biswas</span>, <span class="hlFld-ContribAuthor ">Linda  Brockunier</span>, <span class="hlFld-ContribAuthor ">Nicole  Buist</span>, <span class="hlFld-ContribAuthor ">Duane  Burnette</span>, <span class="hlFld-ContribAuthor ">Mark  Cartwright</span>, <span class="hlFld-ContribAuthor ">Samuel  Chackalamannil</span>, <span class="hlFld-ContribAuthor ">Robert  Chase</span>, <span class="hlFld-ContribAuthor ">Mariappan  Chelliah</span>, <span class="hlFld-ContribAuthor ">Austin  Chen</span>, <span class="hlFld-ContribAuthor ">Martin  Clasby</span>, <span class="hlFld-ContribAuthor ">Vincent J.  Colandrea</span>, <span class="hlFld-ContribAuthor ">Ian W.  Davies</span>, <span class="hlFld-ContribAuthor ">Keith  Eagen</span>, <span class="hlFld-ContribAuthor ">Zhuyan  Guo</span>, <span class="hlFld-ContribAuthor ">Yongxin  Han</span>, <span class="hlFld-ContribAuthor ">John  Howe</span>, <span class="hlFld-ContribAuthor ">Charles  Jayne</span>, <span class="hlFld-ContribAuthor ">Hubert  Josien</span>, <span class="hlFld-ContribAuthor ">Stacia  Kargman</span>, <span class="hlFld-ContribAuthor ">Karen  Marcantonio</span>, <span class="hlFld-ContribAuthor ">Shouwu  Miao</span>, <span class="hlFld-ContribAuthor ">Randy  Miller</span>, <span class="hlFld-ContribAuthor ">Andrew  Nolting</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Murali  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Rebecca T.  Ruck</span>, <span class="hlFld-ContribAuthor ">Unmesh  Shah</span>, <span class="hlFld-ContribAuthor ">Aileen  Soriano</span>, <span class="hlFld-ContribAuthor ">Donald  Sperbeck</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Yan  Xia</span>, and <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 111-116. <a href="https://doi.org/10.1021/acsmedchemlett.5b00425" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00425%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BMK-8831%25252C%252BA%252BNovel%252BSpiro-Proline%252BMacrocycle%252Bas%252Ba%252BPan-Genotypic%252BHCV-NS3%25252F4a%252BProtease%252BInhibitor%26aulast%3DNeelamkavil%26aufirst%3DSanthosh%2BF.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09112015%26date%3D22122015%26date%3D23122015%26date%3D14012016%26date%3D22122015%26volume%3D7%26issue%3D1%26spage%3D111%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaëlle  Milanole</span>, <span class="hlFld-ContribAuthor ">Floris  Andriessen</span>, <span class="hlFld-ContribAuthor ">Gérald  Lemonnier</span>, <span class="hlFld-ContribAuthor ">Muriel  Sebban</span>, <span class="hlFld-ContribAuthor ">Gaël  Coadou</span>, <span class="hlFld-ContribAuthor ">Samuel  Couve-Bonnaire</span>, <span class="hlFld-ContribAuthor ">Jean-François  Bonfanti</span>, <span class="hlFld-ContribAuthor ">Philippe  Jubault</span>, and <span class="hlFld-ContribAuthor ">Xavier  Pannecoucke</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward the Synthesis of Fluorinated Analogues of HCV NS3/4A Serine Protease Inhibitors Using Methyl α-Amino-β-fluoro-β-vinylcyclopropanecarboxylate as Key Intermediate. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (12)
                                     , 2968-2971. <a href="https://doi.org/10.1021/acs.orglett.5b01216" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b01216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b01216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b01216%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DToward%252Bthe%252BSynthesis%252Bof%252BFluorinated%252BAnalogues%252Bof%252BHCV%252BNS3%25252F4A%252BSerine%252BProtease%252BInhibitors%252BUsing%252BMethyl%252B%2525CE%2525B1-Amino-%2525CE%2525B2-fluoro-%2525CE%2525B2-vinylcyclopropanecarboxylate%252Bas%252BKey%252BIntermediate%26aulast%3DMilanole%26aufirst%3DGa%25C3%25ABlle%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D29042015%26date%3D08062015%26date%3D19062015%26volume%3D17%26issue%3D12%26spage%3D2968%26epage%3D2971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Keith D.  Combrink</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Stanley  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">Jan  Thuring</span>, <span class="hlFld-ContribAuthor ">Jianqing  Li</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Min S.  Lee</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Wenying  Li</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Kenneth S.  Santone</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Eric  Hughes</span>, <span class="hlFld-ContribAuthor ">Caly  Chien</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, and <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1708-1729. <a href="https://doi.org/10.1021/jm401840s" title="DOI URL">https://doi.org/10.1021/jm401840s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401840s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401840s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEarly%252BClinical%252BEvaluation%252Bof%252BBMS-605339%25252C%252Ba%252BPotent%252Band%252BOrally%252BEfficacious%252BTripeptidic%252BAcylsulfonamide%252BNS3%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DScola%26aufirst%3DPaul%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27112013%26date%3D20022014%26date%3D13032014%26volume%3D57%26issue%3D5%26spage%3D1708%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Steven  Levine</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Luciano  Mueller</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Adams</span>, <span class="hlFld-ContribAuthor ">James  Loy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Lucy  Sun</span>, <span class="hlFld-ContribAuthor ">William  Warner</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, and <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1730-1752. <a href="https://doi.org/10.1021/jm500297k" title="DOI URL">https://doi.org/10.1021/jm500297k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500297k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500297k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BAsunaprevir%252B%252528BMS-650032%252529%25252C%252BAn%252BOrally%252BEfficacious%252BNS3%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DScola%26aufirst%3DPaul%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24022014%26date%3D05032014%26date%3D13032014%26date%3D24022014%26volume%3D57%26issue%3D5%26spage%3D1730%26epage%3D1752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ananda Kumar  Konreddy</span>, <span class="hlFld-ContribAuthor ">Massaki  Toyama</span>, <span class="hlFld-ContribAuthor ">Wataru  Ito</span>, <span class="hlFld-ContribAuthor ">Chandralata  Bal</span>, <span class="hlFld-ContribAuthor ">Masanori  Baba</span>, and <span class="hlFld-ContribAuthor ">Ashoke  Sharon</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-HCV Activity of 4-Hydroxyamino α-Pyranone Carboxamide Analogues. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (3)
                                     , 259-263. <a href="https://doi.org/10.1021/ml400432f" title="DOI URL">https://doi.org/10.1021/ml400432f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml400432f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml400432f%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BAnti-HCV%252BActivity%252Bof%252B4-Hydroxyamino%252B%2525CE%2525B1-Pyranone%252BCarboxamide%252BAnalogues%26aulast%3DKonreddy%26aufirst%3DAnanda%2BKumar%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D30102013%26date%3D03122013%26date%3D09122013%26date%3D13032014%26date%3D03122013%26volume%3D5%26issue%3D3%26spage%3D259%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vrushabendra  Basavanna</span>, <span class="hlFld-ContribAuthor ">Srikantamurthy  Ningaiah</span>, <span class="hlFld-ContribAuthor ">Manasa  Chandramouli</span>, <span class="hlFld-ContribAuthor ">Anjali  Sobha</span>, <span class="hlFld-ContribAuthor ">Shridevi  Doddamani</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolinyl-pyrazoles: synthesis and pharmacological evolution in the recent decennial. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2021,</strong> <em>18 </em>
                                    (7)
                                     , 1479-1522. <a href="https://doi.org/10.1007/s13738-020-02152-1" title="DOI URL">https://doi.org/10.1007/s13738-020-02152-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-020-02152-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-020-02152-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DQuinolinyl-pyrazoles%25253A%252Bsynthesis%252Band%252Bpharmacological%252Bevolution%252Bin%252Bthe%252Brecent%252Bdecennial%26aulast%3DBasavanna%26aufirst%3DVrushabendra%26date%3D2021%26date%3D2021%26volume%3D18%26issue%3D7%26spage%3D1479%26epage%3D1522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashley N.  Matthew</span>, <span class="hlFld-ContribAuthor ">Jacqueto  Zephyr</span>, <span class="hlFld-ContribAuthor ">Desaboini  Nageswara Rao</span>, <span class="hlFld-ContribAuthor ">Mina  Henes</span>, <span class="hlFld-ContribAuthor ">Wasih  Kamran</span>, <span class="hlFld-ContribAuthor ">Klajdi  Kosovrasti</span>, <span class="hlFld-ContribAuthor ">Adam K.  Hedger</span>, <span class="hlFld-ContribAuthor ">Gordon J.  Lockbaum</span>, <span class="hlFld-ContribAuthor ">Jennifer  Timm</span>, <span class="hlFld-ContribAuthor ">Akbar  Ali</span>, <span class="hlFld-ContribAuthor ">Nese  Kurt Yilmaz</span>, <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>, . </span><span class="cited-content_cbyCitation_article-title">Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">mBio</span><span> <strong>2020,</strong> <em>11 </em>
                                    (2)
                                     <a href="https://doi.org/10.1128/mBio.00172-20" title="DOI URL">https://doi.org/10.1128/mBio.00172-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mBio.00172-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmBio.00172-20%26sid%3Dliteratum%253Aachs%26jtitle%3DmBio%26atitle%3DAvoiding%252BDrug%252BResistance%252Bby%252BSubstrate%252BEnvelope-Guided%252BDesign%25253A%252BToward%252BPotent%252Band%252BRobust%252BHCV%252BNS3%25252F4A%252BProtease%252BInhibitors%26aulast%3DMatthew%26aufirst%3DAshley%2BN.%26date%3D2020%26volume%3D11%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O. A.  Tevs</span>, <span class="hlFld-ContribAuthor ">Ya. V.  Veremeychik</span>, <span class="hlFld-ContribAuthor ">O. A.  Lodochnikova</span>, <span class="hlFld-ContribAuthor ">V. V.  Plemenkov</span>, <span class="hlFld-ContribAuthor ">I. A.  Litvinov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Hybrid Pharmacophores Based on Adducts of N-Sulfinylaniline and Norbornadiene. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2018,</strong> <em>88 </em>
                                    (11)
                                     , 2438-2441. <a href="https://doi.org/10.1134/S1070363218110300" title="DOI URL">https://doi.org/10.1134/S1070363218110300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363218110300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363218110300%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DSynthesis%252Bof%252BHybrid%252BPharmacophores%252BBased%252Bon%252BAdducts%252Bof%252BN-Sulfinylaniline%252Band%252BNorbornadiene%26aulast%3DTevs%26aufirst%3DO.%2BA.%26date%3D2018%26date%3D2018%26volume%3D88%26issue%3D11%26spage%3D2438%26epage%3D2441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in the Chemistry of Pyrazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 55-107. <a href="https://doi.org/10.1016/bs.aihch.2018.02.001" title="DOI URL">https://doi.org/10.1016/bs.aihch.2018.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2018.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2018.02.001%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BDevelopments%252Bin%252Bthe%252BChemistry%252Bof%252BPyrazoles%26aulast%3DBrown%26aufirst%3DAndrew%2BW.%26date%3D2018%26spage%3D55%26epage%3D107%26pub%3DElsevier%26date%3D2018%26volume%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sulejman  Alihodžić</span>, <span class="hlFld-ContribAuthor ">Mirjana  Bukvić</span>, <span class="hlFld-ContribAuthor ">Ivaylo J.  Elenkov</span>, <span class="hlFld-ContribAuthor ">Antun  Hutinec</span>, <span class="hlFld-ContribAuthor ">Sanja  Koštrun</span>, <span class="hlFld-ContribAuthor ">Dijana  Pešić</span>, <span class="hlFld-ContribAuthor ">Gordon  Saxty</span>, <span class="hlFld-ContribAuthor ">Linda  Tomašković</span>, <span class="hlFld-ContribAuthor ">Dinko  Žiher</span>. </span><span class="cited-content_cbyCitation_article-title">Current Trends in Macrocyclic Drug Discovery and beyond -Ro5. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 113-233. <a href="https://doi.org/10.1016/bs.pmch.2018.01.002" title="DOI URL">https://doi.org/10.1016/bs.pmch.2018.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2018.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2018.01.002%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252BTrends%252Bin%252BMacrocyclic%252BDrug%252BDiscovery%252Band%252Bbeyond%252B-Ro5%26aulast%3DAlihod%25C5%25BEi%25C4%2587%26aufirst%3DSulejman%26date%3D2018%26spage%3D113%26epage%3D233%26pub%3DElsevier%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mao  Quan</span>, <span class="hlFld-ContribAuthor ">Liang  Wu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Yang</span>, <span class="hlFld-ContribAuthor ">Wanbin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Pd(
              ii
              ), Ni(
              ii
              ) and Co(
              ii
              )-catalyzed enantioselective additions of organoboron reagents to ketimines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (74)
                                     , 10394-10404. <a href="https://doi.org/10.1039/C8CC04932G" title="DOI URL">https://doi.org/10.1039/C8CC04932G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC04932G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC04932G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DPd%252528%252Bii%252B%252529%25252C%252BNi%252528%252Bii%252B%252529%252Band%252BCo%252528%252Bii%252B%252529-catalyzed%252Benantioselective%252Badditions%252Bof%252Borganoboron%252Breagents%252Bto%252Bketimines%26aulast%3DQuan%26aufirst%3DMao%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D74%26spage%3D10394%26epage%3D10404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khalid  Karrouchi</span>, <span class="hlFld-ContribAuthor ">Smaail  Radi</span>, <span class="hlFld-ContribAuthor ">Youssef  Ramli</span>, <span class="hlFld-ContribAuthor ">Jamal  Taoufik</span>, <span class="hlFld-ContribAuthor ">Yahia  Mabkhot</span>, <span class="hlFld-ContribAuthor ">Faiz  Al-aizari</span>, <span class="hlFld-ContribAuthor ">M’hammed  Ansar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (1)
                                     , 134. <a href="https://doi.org/10.3390/molecules23010134" title="DOI URL">https://doi.org/10.3390/molecules23010134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23010134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23010134%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BPharmacological%252BActivities%252Bof%252BPyrazole%252BDerivatives%25253A%252BA%252BReview%26aulast%3DKarrouchi%26aufirst%3DKhalid%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D1%26spage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ola H.  Rizk</span>, <span class="hlFld-ContribAuthor ">Omaima G.  Shaaban</span>, <span class="hlFld-ContribAuthor ">Abeer E.  Abdel Wahab</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Oxadiazolyl, Pyrazolyl and Thiazolyl Derivatives of Thiophene-2-Carboxamide as Antimicrobial and Anti-HCV Agents. </span><span class="cited-content_cbyCitation_journal-name">The Open Medicinal Chemistry Journal</span><span> <strong>2017,</strong> <em>11 </em>
                                    (1)
                                     , 38-53. <a href="https://doi.org/10.2174/1874104501711010038" title="DOI URL">https://doi.org/10.2174/1874104501711010038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1874104501711010038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1874104501711010038%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Open%2520Medicinal%2520Chemistry%2520Journal%26atitle%3DSynthesis%252Bof%252BOxadiazolyl%25252C%252BPyrazolyl%252Band%252BThiazolyl%252BDerivatives%252Bof%252BThiophene-2-Carboxamide%252Bas%252BAntimicrobial%252Band%252BAnti-HCV%252BAgents%26aulast%3DRizk%26aufirst%3DOla%2BH.%26date%3D2017%26volume%3D11%26issue%3D1%26spage%3D38%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Grychowska</span>, <span class="hlFld-ContribAuthor ">Bartłomiej  Kubica</span>, <span class="hlFld-ContribAuthor ">Marcin  Drop</span>, <span class="hlFld-ContribAuthor ">Evelina  Colacino</span>, <span class="hlFld-ContribAuthor ">Xavier  Bantreil</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, <span class="hlFld-ContribAuthor ">Gilles  Subra</span>, <span class="hlFld-ContribAuthor ">Paweł  Zajdel</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lamaty</span>. </span><span class="cited-content_cbyCitation_article-title">Application of the ring-closing metathesis to the formation of 2-aryl-1H-pyrrole-3-carboxylates as building blocks for biologically active compounds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (47)
                                     , 7462-7469. <a href="https://doi.org/10.1016/j.tet.2016.09.059" title="DOI URL">https://doi.org/10.1016/j.tet.2016.09.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.09.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.09.059%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DApplication%252Bof%252Bthe%252Bring-closing%252Bmetathesis%252Bto%252Bthe%252Bformation%252Bof%252B2-aryl-1H-pyrrole-3-carboxylates%252Bas%252Bbuilding%252Bblocks%252Bfor%252Bbiologically%252Bactive%252Bcompounds%26aulast%3DGrychowska%26aufirst%3DKatarzyna%26date%3D2016%26volume%3D72%26issue%3D47%26spage%3D7462%26epage%3D7469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Garima  Verma</span>, <span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">The therapeutic voyage of pyrazole and its analogs: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>120 </em>, 170-201. <a href="https://doi.org/10.1016/j.ejmech.2016.04.077" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.077%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Btherapeutic%252Bvoyage%252Bof%252Bpyrazole%252Band%252Bits%252Banalogs%25253A%252BA%252Breview%26aulast%3DKhan%26aufirst%3DMohemmed%2BFaraz%26date%3D2016%26volume%3D120%26spage%3D170%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O. A.  Tevs</span>, <span class="hlFld-ContribAuthor ">Ya. V.  Veremeichik</span>, <span class="hlFld-ContribAuthor ">D. N.  Shurpik</span>, <span class="hlFld-ContribAuthor ">O. A.  Lodochnikova</span>, <span class="hlFld-ContribAuthor ">V. V.  Plemenkov</span>. </span><span class="cited-content_cbyCitation_article-title">Acylated benzothiazinesulfoneamides: Synthesis and molecular structure. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2016,</strong> <em>86 </em>
                                    (8)
                                     , 1850-1853. <a href="https://doi.org/10.1134/S1070363216080120" title="DOI URL">https://doi.org/10.1134/S1070363216080120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363216080120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363216080120%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DAcylated%252Bbenzothiazinesulfoneamides%25253A%252BSynthesis%252Band%252Bmolecular%252Bstructure%26aulast%3DTevs%26aufirst%3DO.%2BA.%26date%3D2016%26date%3D2016%26volume%3D86%26issue%3D8%26spage%3D1850%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hangfei  Qi</span>, <span class="hlFld-ContribAuthor ">Nicholas C  Wu</span>, <span class="hlFld-ContribAuthor ">Yushen  Du</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Ren  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">High-resolution genetic profile of viral genomes: why it matters. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Virology</span><span> <strong>2015,</strong> <em>14 </em>, 62-70. <a href="https://doi.org/10.1016/j.coviro.2015.08.005" title="DOI URL">https://doi.org/10.1016/j.coviro.2015.08.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coviro.2015.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coviro.2015.08.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Virology%26atitle%3DHigh-resolution%252Bgenetic%252Bprofile%252Bof%252Bviral%252Bgenomes%25253A%252Bwhy%252Bit%252Bmatters%26aulast%3DQi%26aufirst%3DHangfei%26date%3D2015%26volume%3D14%26spage%3D62%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangyuan  Shi</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a series of novel compounds with moderate anti-hepatitis C virus NS3 protease activity in vitro. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5539-5545. <a href="https://doi.org/10.1016/j.bmc.2015.07.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252Bcompounds%252Bwith%252Bmoderate%252Banti-hepatitis%252BC%252Bvirus%252BNS3%252Bprotease%252Bactivity%252Bin%252Bvitro%26aulast%3DShi%26aufirst%3DFangyuan%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5539%26epage%3D5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>, <span class="hlFld-ContribAuthor ">John W.  Butcher</span>, <span class="hlFld-ContribAuthor ">Kevin T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Charles J.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Romano</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Kimberly J.  Bush</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>, <span class="hlFld-ContribAuthor ">M. Katharine  Holloway</span>, <span class="hlFld-ContribAuthor ">Steven  Harper</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Marcello  DiFilippo</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">John  Swestock</span>, <span class="hlFld-ContribAuthor ">Jeff  Fritzen</span>, <span class="hlFld-ContribAuthor ">Steven S.  Carroll</span>, <span class="hlFld-ContribAuthor ">Christine  Burlein</span>, <span class="hlFld-ContribAuthor ">Jillian M.  DiMuzio</span>, <span class="hlFld-ContribAuthor ">Adam  Gates</span>, <span class="hlFld-ContribAuthor ">Donald J.  Graham</span>, <span class="hlFld-ContribAuthor ">Qian  Huang</span>, <span class="hlFld-ContribAuthor ">Stephanie  McClain</span>, <span class="hlFld-ContribAuthor ">Carolyn  McHale</span>, <span class="hlFld-ContribAuthor ">Mark W.  Stahlhut</span>, <span class="hlFld-ContribAuthor ">Stuart  Black</span>, <span class="hlFld-ContribAuthor ">Robert  Chase</span>, <span class="hlFld-ContribAuthor ">Aileen  Soriano</span>, <span class="hlFld-ContribAuthor ">Christine M.  Fandozzi</span>, <span class="hlFld-ContribAuthor ">Anne  Taylor</span>, <span class="hlFld-ContribAuthor ">Nicole  Trainor</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>. </span><span class="cited-content_cbyCitation_article-title">P2-Quinazolinones and Bis-Macrocycles as New Templates for Next-Generation Hepatitis C Virus NS3/4a Protease Inhibitors: Discovery of MK-2748 and MK-6325. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (4)
                                     , 727-735. <a href="https://doi.org/10.1002/cmdc.201402558" title="DOI URL">https://doi.org/10.1002/cmdc.201402558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402558%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DP2-Quinazolinones%252Band%252BBis-Macrocycles%252Bas%252BNew%252BTemplates%252Bfor%252BNext-Generation%252BHepatitis%2525E2%252580%252585C%252BVirus%252BNS3%25252F4a%252BProtease%252BInhibitors%25253A%252BDiscovery%252Bof%252BMK-2748%252Band%252BMK-6325%26aulast%3DRudd%26aufirst%3DMichael%2BT.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3D727%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mao  Quan</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Yang</span>, <span class="hlFld-ContribAuthor ">Fang  Xie</span>, <span class="hlFld-ContribAuthor ">Ilya D.  Gridnev</span>, <span class="hlFld-ContribAuthor ">Wanbin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Pd(
              ii
              )-catalyzed asymmetric addition of arylboronic acids to cyclic N-sulfonyl ketimine esters and a DFT study of its mechanism. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2015,</strong> <em>2 </em>
                                    (4)
                                     , 398-402. <a href="https://doi.org/10.1039/C4QO00347K" title="DOI URL">https://doi.org/10.1039/C4QO00347K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4QO00347K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4QO00347K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DPd%252528%252Bii%252B%252529-catalyzed%252Basymmetric%252Baddition%252Bof%252Barylboronic%252Bacids%252Bto%252Bcyclic%252BN-sulfonyl%252Bketimine%252Besters%252Band%252Ba%252BDFT%252Bstudy%252Bof%252Bits%252Bmechanism%26aulast%3DQuan%26aufirst%3DMao%26date%3D2015%26date%3D2015%26volume%3D2%26issue%3D4%26spage%3D398%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Current race in the development of DAAs (direct-acting antivirals) against HCV. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2014,</strong> <em>89 </em>
                                    (4)
                                     , 441-452. <a href="https://doi.org/10.1016/j.bcp.2014.04.005" title="DOI URL">https://doi.org/10.1016/j.bcp.2014.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2014.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2014.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DCurrent%252Brace%252Bin%252Bthe%252Bdevelopment%252Bof%252BDAAs%252B%252528direct-acting%252Bantivirals%252529%252Bagainst%252BHCV%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2014%26volume%3D89%26issue%3D4%26spage%3D441%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400121t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>–<b>20</b> and Intermediate <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400121t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, <b>22a</b>–<b>c</b>, NMP, 70 °C; (b) 1 M LiOH, THF, MeOH; (c) <i>i</i>-BuCOCl, Et<sub>3</sub>N, <b>23a</b> or <b>23b</b>, LiHMDS; (d) HCl/dioxanes; (e) corresponding alkyl chloroformate, Et<sub>3</sub>N, THF, or corresponding acid, TBTU or HATU, Et<sub>3</sub>N, DMF.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/medium/jm-2013-00121t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-Alkoxy-4-hydroxyquinoline Derivatives <b>23a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm400121t/production/images/large/jm-2013-00121t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400121t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) R2OH, Et<sub>2</sub>O, HCl(g) 0 °C to rt; (b) R2OH, 40 °C, 4 h; (c) Ph<sub>2</sub>O, 230 °C, 8–10 min.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0lg-lsApMaH5Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lavanchy, D.</span><span> </span><span class="NLM_article-title">The global burden of hepatitis C</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=74-81&author=D.+Lavanchy&title=The+global+burden+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavanchy%26aufirst%3DD.%26atitle%3DThe%2520global%2520burden%2520of%2520hepatitis%2520C%26jtitle%3DLiver%2520Int.%26date%3D2009%26volume%3D29%26spage%3D74%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forns, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronlein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G. G.</span><span> </span><span class="NLM_article-title">Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1347-1355&author=H.+Hinrichsenauthor=Y.+Benhamouauthor=H.+Wedemeyerauthor=M.+Reiserauthor=R.+E.+Sentjensauthor=J.+L.+Callejaauthor=X.+Fornsauthor=A.+Erhardtauthor=J.+Cronleinauthor=R.+L.+Chavesauthor=C.+L.+Yongauthor=G.+Nehmizauthor=G.+G.+Steinmann&title=Short-term+antiviral+efficacy+of+BILN+2061%2C+a+hepatitis+C+virus+serine+protease+inhibitor%2C+in+hepatitis+C+genotype+1+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DReiser%26aufirst%3DM.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DForns%26aufirst%3DX.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DCronlein%26aufirst%3DJ.%26aulast%3DChaves%26aufirst%3DR.%2BL.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DSteinmann%26aufirst%3DG.%2BG.%26atitle%3DShort-term%2520antiviral%2520efficacy%2520of%2520BILN%25202061%252C%2520a%2520hepatitis%2520C%2520virus%2520serine%2520protease%2520inhibitor%252C%2520in%2520hepatitis%2520C%2520genotype%25201%2520patients%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.+P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.%2BP.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Poordad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boparai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNubile, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sniukiene, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronowicki, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SPRINT-2 Investigators.</span><span> </span><span class="NLM_article-title">Boceprevir for untreated chronic HCV genotype 1 infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1056%2FNEJMoa1010494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=21449783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Chtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=1195-1206&author=F.+Poordadauthor=J.+McConeauthor=B.+R.+Baconauthor=S.+Brunoauthor=M.+P.+Mannsauthor=M.+S.+Sulkowskiauthor=I.+M.+Jacobsonauthor=K.+R.+Reddyauthor=Z.+D.+Goodmanauthor=N.+Boparaiauthor=M.+J.+DiNubileauthor=V.+Sniukieneauthor=C.+A.+Brassauthor=J.+K.+Albrechtauthor=J.+P.+Bronowickiauthor=SPRINT-2+Investigators.&title=Boceprevir+for+untreated+chronic+HCV+genotype+1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Boceprevir for untreated chronic HCV genotype 1 infection</span></div><div class="casAuthors">Poordad, Fred; McCone, Jonathan, Jr.; Bacon, Bruce; Bruno, Savino; Manns, Michael P.; Sulkowski, Mark S.; Jacobson, Ira M.; Rajender Reddy, K.; Goodman, Zachary D.; Boparai, Navdeep; DiNubile, Mark J.; Sniukiene, Vilma; Brass, Clifford A.; Albrecht, Janice K.; Bronowicki, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1195-1206</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Peginterferon-ribavirin therapy is the current std. of care for chronic infection with hepatitis C virus (HCV).  The rate of sustained virol. response has been below 50% in cases of HCV genotype 1 infection.  Boceprevir, a potent oral HCV-protease inhibitor, has been evaluated as an addnl. treatment in phase 1 and phase 2 studies.  We conducted a double-blind study in which previously untreated adults with HCV genotype 1 infection were randomly assigned to one of three groups.  In all three groups, peginterferon alfa-2b and ribavirin were administered for 4 wk (the lead- in period).  Subsequently, group 1 (the control group) received placebo plus peginterferon-ribavirin for 44 wk; group 2 received boceprevir plus peginterferon-ribavirin for 24 wk, and those with a detectable HCV RNA level between weeks 8 and 24 received placebo plus peginterferon-ribavirin for an addnl. 20 wk; and group 3 received boceprevir plus peginterferon-ribavirin for 44 wk.  Non-black patients and black patients were enrolled and analyzed sep.  A total of 938 non-black and 159 black patients were treated.  In the non-black cohort, a sustained virol. response was achieved in 125 of the 311 patients (40%) in group 1, in 211 of the 316 patients (67%) in group 2 (P < 0.001), and in 213 of the 311 patients (68%) in group 3 (P < 0.001).  In the black cohort, a sustained virol. response was achieved in 12 of the 52 patients (23%) in group 1, in 22 of the 52 patients (42%) in group 2 (P = 0.04), and in 29 of the 55 patients (53%) in group 3 (P = 0.004).  In group 2, a total of 44% of patients received peginterferon-ribavirin for 28 wk.  Anemia led to dose redns. in 13% of controls and 21% of boceprevir recipients, with discontinuations in 1% and 2%, resp.  The addn. of boceprevir to std. therapy with peginterferon-ribavirin, as compared with std. therapy alone, significantly increased the rates of sustained virol. response in previously untreated adults with chronic HCV genotype 1 infection.  The rates were similar with 24 wk and 44 wk of boceprevir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCdL0rY0lmGrVg90H21EOLACvtfcHk0licJwmVbc8eQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Chtrc%253D&md5=47ea838a941fdf7f9a27350a403e794e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1010494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1010494%26sid%3Dliteratum%253Aachs%26aulast%3DPoordad%26aufirst%3DF.%26aulast%3DMcCone%26aufirst%3DJ.%26aulast%3DBacon%26aufirst%3DB.%2BR.%26aulast%3DBruno%26aufirst%3DS.%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DSulkowski%26aufirst%3DM.%2BS.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DGoodman%26aufirst%3DZ.%2BD.%26aulast%3DBoparai%26aufirst%3DN.%26aulast%3DDiNubile%26aufirst%3DM.%2BJ.%26aulast%3DSniukiene%26aufirst%3DV.%26aulast%3DBrass%26aufirst%3DC.%2BA.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26aulast%3DBronowicki%26aufirst%3DJ.%2BP.%26aulast%3D%26atitle%3DBoceprevir%2520for%2520untreated%2520chronic%2520HCV%2520genotype%25201%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D1195%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusheiko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bisceglie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzowej, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferenci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flisiak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzetto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shouval, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankoh, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ADVANCE Study Team.</span><span> </span><span class="NLM_article-title">Telaprevir for previously untreated chronic hepatitis C virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">2405</span><span class="NLM_x">–</span> <span class="NLM_lpage">2416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1056%2FNEJMoa1012912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=21696307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVCku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2011&pages=2405-2416&author=I.+M.+Jacobsonauthor=J.+G.+McHutchisonauthor=G.+Dusheikoauthor=A.+M.+Di+Bisceglieauthor=K.+R.+Reddyauthor=N.+H.+Bzowejauthor=P.+Marcellinauthor=A.+J.+Muirauthor=P.+Ferenciauthor=R.+Flisiakauthor=J.+Georgeauthor=M.+Rizzettoauthor=D.+Shouvalauthor=R.+Solaauthor=R.+A.+Tergauthor=E.+M.+Yoshidaauthor=N.+Addaauthor=L.+Bengtssonauthor=A.+J.+Sankohauthor=T.+L.+Kiefferauthor=S.+Georgeauthor=R.+S.+Kauffmanauthor=S.+Zeuzemauthor=ADVANCE+Study+Team.&title=Telaprevir+for+previously+untreated+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Telaprevir for previously untreated chronic hepatitis C virus infection</span></div><div class="casAuthors">Jacobson, Ira M.; McHutchison, John G.; Dusheiko, Geoffrey; Di Bisceglie, Adrian M.; Reddy, K. Rajender; Bzowej, Natalie H.; Marcellin, Patrick; Muir, Andrew J.; Ferenci, Peter; Flisiak, Robert; George, Jacob; Rizzetto, Mario; Shouval, Daniel; Sola, Ricard; Terg, Ruben A.; Yoshida, Eric M.; Adda, Nathalie; Bengtsson, Leif; Sankoh, Abdul J.; Kieffer, Tara L.; George, Shelley; Kauffman, Robert S.; Zeuzem, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">364</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2405-2416</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with peginterferon-ribavirin, as compared with peginterferon-ribavirin alone, has shown improved efficacy, with potential for shortening the duration of treatment in a majority of patients.  METHODS: In this international, phase 3, randomized, double-blind, placebo-controlled trial, we assigned 1088 patients with HCV genotype 1 infection who had not received previous treatment for the infection to one of three groups: a group receiving telaprevir combined with peginterferon alfa-2a and ribavirin for 12 wk (T12PR group), followed by peginterferon-ribavirin alone for 12 wk if HCV RNA was undetectable at weeks 4 and 12 or for 36 wk if HCV RNA was detectable at either time point; a group receiving telaprevir with peginterferon-ribavirin for 8 wk and placebo with peginterferon-ribavirin for 4 wk (T8PR group), followed by 12 or 36 wk of peginterferon-ribavirin on the basis of the same HCV RNA criteria; or a group receiving placebo with peginterferon-ribavirin for 12 wk, followed by 36 wk of peginterferon-ribavirin (PR group).  The primary end point was the proportion of patients who had undetectable plasma HCV RNA 24 wk after the last planned dose of study treatment (sustained virol. response).  RESULTS: Significantly more patients in the T12PR or T8PR group than in the PR group had a sustained virol. response (75% and 69%, resp., vs. 44%; P < 0.001 for the comparison of the T12PR or T8PR group with the PR group).  A total of 58% of the patients treated with telaprevir were eligible to receive 24 wk of total treatment.  Anemia, gastrointestinal side effects, and skin rashes occurred at a higher incidence among patients receiving telaprevir than among those receiving peginterferon-ribavirin alone.  The overall rate of discontinuation of the treatment regimen owing to adverse events was 10% in the T12PR and T8PR groups and 7% in the PR group.  CONCLUSIONS: Telaprevir with peginterferon-ribavirin, as compared with peginterferon-ribavirin alone, was assocd. with significantly improved rates of sustained virol. response in patients with HCV genotype 1 infection who had not received previous treatment, with only 24 wk of therapy administered in the majority of patients. (Funded by Vertex Pharmaceuticals and Tibotec; ADVANCE ClinicalTrials.gov no., NCT00627926.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcImqLMQ63DLVg90H21EOLACvtfcHk0lh6M2fGJVYo5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVCku7Y%253D&md5=16aff3164348c2bfe80fc14121eb7b93</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1012912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1012912%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DDusheiko%26aufirst%3DG.%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DBzowej%26aufirst%3DN.%2BH.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DMuir%26aufirst%3DA.%2BJ.%26aulast%3DFerenci%26aufirst%3DP.%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DRizzetto%26aufirst%3DM.%26aulast%3DShouval%26aufirst%3DD.%26aulast%3DSola%26aufirst%3DR.%26aulast%3DTerg%26aufirst%3DR.%2BA.%26aulast%3DYoshida%26aufirst%3DE.%2BM.%26aulast%3DAdda%26aufirst%3DN.%26aulast%3DBengtsson%26aufirst%3DL.%26aulast%3DSankoh%26aufirst%3DA.%2BJ.%26aulast%3DKieffer%26aufirst%3DT.%2BL.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DR.%2BS.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3D%26atitle%3DTelaprevir%2520for%2520previously%2520untreated%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D364%26spage%3D2405%26epage%3D2416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Preclinical characterization of BI 201335, a C-terminal carbosylic acid inhibitor of the hepatitis C virus NS3-NS4A protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4611</span><span class="NLM_x">–</span> <span class="NLM_lpage">4618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4611-4618&author=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunetauthor=M.+Amadauthor=R.+C.+Bethellauthor=G.+Bolgerauthor=M.+G.+Cordingleyauthor=J.+Duanauthor=M.+Garneauauthor=L.+Lagac%C3%A9author=D.+Thibeaultauthor=G.+Kukolj&title=Preclinical+characterization+of+BI+201335%2C+a+C-terminal+carbosylic+acid+inhibitor+of+the+hepatitis+C+virus+NS3-NS4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DPreclinical%2520characterization%2520of%2520BI%2520201335%252C%2520a%2520C-terminal%2520carbosylic%2520acid%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4611%26epage%3D4618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonacini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boecher, W. O.</span><span> </span><span class="NLM_article-title">Potency, safety and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1016%2Fj.jhep.2010.08.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=21145839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1114-1122&author=M.+P.+Mannsauthor=M.+Bourli%C3%A8reauthor=Y.+Benhamouauthor=S.+Polauthor=M.+Bonaciniauthor=C.+Trepoauthor=D.+Wrightauthor=T.+Bergauthor=J.+L.+Callejaauthor=P.+W.+Whiteauthor=J.+O.+Sternauthor=G.+Steinmannauthor=C.+L.+Yongauthor=G.+Kukoljauthor=J.+Schererauthor=W.+O.+Boecher&title=Potency%2C+safety+and+pharmacokinetics+of+the+NS3%2F4A+protease+inhibitor+BI201335+in+patients+with+chronic+HCV+genotype-1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection</span></div><div class="casAuthors">Manns, Michael P.; Bourliere, Marc; Benhamou, Yves; Pol, Stanislas; Bonacini, Maurizio; Trepo, Christian; Wright, David; Berg, Thomas; Calleja, Jose L.; White, Peter W.; Stern, Jerry O.; Steinmann, Gerhard; Yong, Chan-Loi; Kukolj, George; Scherer, Joe; Boecher, Wulf O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1114-1122</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background & Aims: BI201335 is a highly specific and potent HCV protease inhibitor.  This multiple rising dose trial evaluated antiviral activity and safety in chronic HCV genotype-1 patients.  Methods: Thirty-four treatment-naive patients were randomized to monotherapy with placebo or BI201335 at 20-240 mg once-daily for 14 days, followed by combination with pegylated interferon alfa/ribavirin (PegIFN/RBV) through Day 28.  Nineteen treatment-experienced patients received 48-240 mg BI201335 once-daily with PegIFN/RBV for 28 days.  HCV-RNA was measured with Roche COBAS TaqMan.  Results: In treatment-naive patients, median maximal viral load (VL) redns. during 14-day monotherapy were -3.0, -3.6, -3.7, and -4.2 log10 for the 20, 48, 120, and 240 mg groups.  VL breakthroughs (≥1 log10 from nadir) were seen in most patients on monotherapy and were caused by NS3/4A variants (R155K, D168V) conferring in vitro resistance to BI201335.  Adding PegIFN/RBV at Days 15-28 led to continuous viral load redns. in most patients.  In treatment-experienced patients, treatment with BI201335 and PegIFN/RBV achieved VL <25 IU/mL at Day 28 in 3/6, 4/7, and 5/6 patients in the 48, 120, and 240 mg dose groups.  VL breakthroughs were obsd. during triple combination in only 3/19 patients.  BI201335 was generally well tolerated.  Mild rash or photosensitivity was detected in four patients.  Mild unconjugated hyperbilirubinemia was the only dose-dependent lab. abnormality of BI201335.  BI201335 elimination half-life supports once-daily dosing.  Conclusions: BI201335 combined with PegIFN/RBV was well tolerated and induced strong antiviral responses.  These results support further development of BI201335 in HCV genotype-1 patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBRyXVmCJAfbVg90H21EOLACvtfcHk0lj9m5Tvff-1ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVygsr0%253D&md5=b82161fb58cbfd5bef7f0d59ad7b8b78</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2010.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2010.08.040%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DPol%26aufirst%3DS.%26aulast%3DBonacini%26aufirst%3DM.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DStern%26aufirst%3DJ.%2BO.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DScherer%26aufirst%3DJ.%26aulast%3DBoecher%26aufirst%3DW.%2BO.%26atitle%3DPotency%252C%2520safety%2520and%2520pharmacokinetics%2520of%2520the%2520NS3%252F4A%2520protease%2520inhibitor%2520BI201335%2520in%2520patients%2520with%2520chronic%2520HCV%2520genotype-1%2520infection%26jtitle%3DJ.%2520Hepatol.%26date%3D2011%26volume%3D54%26spage%3D1114%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massariol, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spickler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">In vitro resistance profile of the hepatitis C virus NS3 protease inhibitor BI 201335</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=569-572&author=L.+Lagaceauthor=P.+W.+Whiteauthor=C.+Bousquetauthor=N.+Dansereauauthor=F.+Doauthor=M.+Llinas-Brunetauthor=M.+Marquisauthor=M.+J.+Massariolauthor=R.+Mauriceauthor=C.+Spicklerauthor=D.+Thibeaultauthor=I.+Trikiauthor=S.+Zhaoauthor=G.+Kukolj&title=In+vitro+resistance+profile+of+the+hepatitis+C+virus+NS3+protease+inhibitor+BI+201335"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DBousquet%26aufirst%3DC.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DDo%26aufirst%3DF.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DMassariol%26aufirst%3DM.%2BJ.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DSpickler%26aufirst%3DC.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTriki%26aufirst%3DI.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DIn%2520vitro%2520resistance%2520profile%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%2520BI%2520201335%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D569%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbinnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijgen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berke, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehertogh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fransen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeiren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivens, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K. A.</span><span> </span><span class="NLM_article-title">In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1878</span><span class="NLM_x">–</span> <span class="NLM_lpage">1887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1878-1887&author=O.+Lenzauthor=T.+Verbinnenauthor=T.+I.+Linauthor=L.+Vijgenauthor=M.+D.+Cummingsauthor=J.+Lindbergauthor=J.+M.+Berkeauthor=P.+Dehertoghauthor=E.+Fransenauthor=A.+Scholliersauthor=K.+Vermeirenauthor=T.+Ivensauthor=P.+Raboissonauthor=M.+Edlundauthor=S.+Stormauthor=L.+Vrangauthor=K.+H.+deauthor=G.+C.+Fanningauthor=K.+A.+Simmen&title=In+vitro+resistance+profile+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+TMC435"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DVerbinnen%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DVijgen%26aufirst%3DL.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLindberg%26aufirst%3DJ.%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26aulast%3DDehertogh%26aufirst%3DP.%26aulast%3DFransen%26aufirst%3DE.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DVermeiren%26aufirst%3DK.%26aulast%3DIvens%26aufirst%3DT.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DStorm%26aufirst%3DS.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3Dde%26aufirst%3DK.%2BH.%26aulast%3DFanning%26aufirst%3DG.%2BC.%26aulast%3DSimmen%26aufirst%3DK.%2BA.%26atitle%3DIn%2520vitro%2520resistance%2520profile%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520TMC435%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D1878%26epage%3D1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Welsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span> </span><span class="NLM_article-title">Will interferon-free regimens prevail?</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=1351-1355&author=C.+Welschauthor=S.+Zeuzem&title=Will+interferon-free+regimens+prevail%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DC.%26aulast%3DZeuzem%26aufirst%3DS.%26atitle%3DWill%2520interferon-free%2520regimens%2520prevail%253F%26jtitle%3DGastroenterology%26date%3D2012%26volume%3D142%26spage%3D1351%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">O’meara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">Molecular mechanism by which a potent hepatitis C virus NS3-NS4A protease inhibitor overcomes emergence of resistance</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">5673</span><span class="NLM_x">–</span> <span class="NLM_lpage">5681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=5673-5681&author=J.+O%E2%80%99mearaauthor=C.+T.+Lemkeauthor=C.+Godboutauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=B.+Moreauauthor=D.+Thibeaultauthor=P.+W.+Whiteauthor=M.+Llin%C3%A0s-Brunet&title=Molecular+mechanism+by+which+a+potent+hepatitis+C+virus+NS3-NS4A+protease+inhibitor+overcomes+emergence+of+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599meara%26aufirst%3DJ.%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DGodbout%26aufirst%3DC.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DMoreau%26aufirst%3DB.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DMolecular%2520mechanism%2520by%2520which%2520a%2520potent%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520protease%2520inhibitor%2520overcomes%2520emergence%2520of%2520resistance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D5673%26epage%3D5681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Campbell, J. A.; Good, A.</span><span> </span><span class="NLM_article-title">Hepatitis C Tripeptide Inhibitors</span>. WO 2002/060926 A2,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+A.+Campbell&author=A.+Good&title=Hepatitis+C+Tripeptide+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26atitle%3DHepatitis%2520C%2520Tripeptide%2520Inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poliakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiklund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiwarter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span> </span><span class="NLM_article-title">Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2551-2568&author=A.+Johanssonauthor=A.+Poliakovauthor=E.+Akerblomauthor=K.+Wiklundauthor=G.+Lindebergauthor=S.+Winiwarterauthor=U.+H.+Danielsonauthor=B.+Samuelssonauthor=A.+Hallberg&title=Acyl+sulfonamides+as+potent+protease+inhibitors+of+the+hepatitis+C+virus+full-length+NS3+%28protease-helicase%2FNTPase%29%3A+a+comparative+study+of+different+C-terminals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DPoliakov%26aufirst%3DA.%26aulast%3DAkerblom%26aufirst%3DE.%26aulast%3DWiklund%26aufirst%3DK.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DHallberg%26aufirst%3DA.%26atitle%3DAcyl%2520sulfonamides%2520as%2520potent%2520protease%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520full-length%2520NS3%2520%2528protease-helicase%252FNTPase%2529%253A%2520a%2520comparative%2520study%2520of%2520different%2520C-terminals%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2551%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ronn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabnis, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerblom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A.</span><span> </span><span class="NLM_article-title">Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=544-559&author=R.+Ronnauthor=Y.+A.+Sabnisauthor=T.+Gossasauthor=E.+Akerblomauthor=U.+H.+Danielsonauthor=A.+Hallbergauthor=A.+Johansson&title=Exploration+of+acyl+sulfonamides+as+carboxylic+acid+replacements+in+protease+inhibitors+of+the+hepatitis+C+virus+full-length+NS3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRonn%26aufirst%3DR.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DGossas%26aufirst%3DT.%26aulast%3DAkerblom%26aufirst%3DE.%26aulast%3DDanielson%26aufirst%3DU.%2BH.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DA.%26atitle%3DExploration%2520of%2520acyl%2520sulfonamides%2520as%2520carboxylic%2520acid%2520replacements%2520in%2520protease%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520full-length%2520NS3%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D544%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lemke, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hucke, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span> </span><span class="NLM_article-title">Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">11434</span><span class="NLM_x">–</span> <span class="NLM_lpage">11443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1074%2Fjbc.M110.211417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=21270126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslKgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=11434-11443&author=C.+T.+Lemkeauthor=N.+Goudreauauthor=S.+Zhaoauthor=O.+Huckeauthor=D.+Thibeaultauthor=M.+Llinas-Brunetauthor=P.+W.+White&title=Combined+X-ray%2C+NMR%2C+and+kinetic+analyses+reveal+uncommon+binding+characteristics+of+the+hepatitis+C+virus+NS3-NS4A+protease+inhibitor+BI+201335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335</span></div><div class="casAuthors">Lemke, Christopher T.; Goudreau, Nathalie; Zhao, Songping; Hucke, Oliver; Thibeault, Diane; Llinas-Brunet, Montse; White, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">11434-11443</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hepatitis C virus infection, a major cause of liver disease worldwide, is curable, but currently approved therapies have suboptimal efficacy.  Supplementing these therapies with direct-acting antiviral agents has the potential to considerably improve treatment prospects for hepatitis C virus-infected patients.  The crit. role played by the viral NS3 protease makes it an attractive target, and despite its shallow, solvent-exposed active site, several potent NS3 protease inhibitors are currently in the clinic.  BI 201335, which is progressing through Phase IIb trials, contains a unique C-terminal carboxylic acid that binds noncovalently to the active site and a bromo-quinoline substitution on its proline residue that provides significant potency.  In this work we have used stopped flow kinetics, x-ray crystallog., and NMR to characterize these distinctive features.  Key findings include: slow assocn. and dissocn. rates within a single-step binding mechanism; the crit. involvement of water mols. in acid binding; and protein side chain rearrangements, a bromine-oxygen halogen bond, and profound pKa changes within the catalytic triad assocd. with binding of the bromo-quinoline moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkdn8YiZZHALVg90H21EOLACvtfcHk0ljQyFKca6mHbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslKgsbs%253D&md5=2281c4bbfd76e34934f129fb61dcf926</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.211417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.211417%26sid%3Dliteratum%253Aachs%26aulast%3DLemke%26aufirst%3DC.%2BT.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26atitle%3DCombined%2520X-ray%252C%2520NMR%252C%2520and%2520kinetic%2520analyses%2520reveal%2520uncommon%2520binding%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3-NS4A%2520protease%2520inhibitor%2520BI%2520201335%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D11434%26epage%3D11443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Yee, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houpis, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frutos, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Keenan, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitous, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridges, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicola, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samstag, W.</span><span> </span><span class="NLM_article-title">Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesis</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">7133</span><span class="NLM_x">–</span> <span class="NLM_lpage">7145</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo060285j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1KgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=7133-7145&author=N.+K.+Yeeauthor=V.+Farinaauthor=I.+N.+Houpisauthor=N.+Haddadauthor=R.+P.+Frutosauthor=F.+Gallouauthor=X.+J.+Wangauthor=X.+Weiauthor=R.+D.+Simpsonauthor=X.+Fengauthor=V.+Fuchsauthor=Y.+Xuauthor=J.+Tanauthor=L.+Zhangauthor=J.+Xuauthor=L.+L.+Smith-Keenanauthor=J.+Vitousauthor=M.+D.+Ridgesauthor=E.+M.+Spinelliauthor=M.+Johnsonauthor=K.+Donsbachauthor=T.+Nicolaauthor=M.+Brennerauthor=E.+Winterauthor=P.+Kreyeauthor=W.+Samstag&title=Efficient+large-scale+synthesis+of+BILN+2061%2C+a+potent+HCV+protease+inhibitor%2C+by+a+convergent+approach+based+on+ring-closing+metathesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Large-Scale Synthesis of BILN 2061, a Potent HCV Protease Inhibitor, by a Convergent Approach Based on Ring-Closing Metathesis</span></div><div class="casAuthors">Yee, Nathan K.; Farina, Vittorio; Houpis, Ioannis N.; Haddad, Nizar; Frutos, Rogelio P.; Gallou, Fabrice; Wang, Xiao-Jun; Wei, Xudong; Simpson, Robert D.; Feng, Xuwu; Fuchs, Victor; Xu, Yibo; Tan, Jonathan; Zhang, Li; Xu, Jinghua; Smith-Keenan, Lana L.; Vitous, Jana; Ridges, Michael D.; Spinelli, Earl M.; Johnson, Michael; Donsbach, Kai; Nicola, Thomas; Brenner, Michael; Winter, Eric; Kreye, Paul; Samstag, Wendelin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7133-7145</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A multistep scalable synthesis of the clin. important hepatitis C virus (HCV) protease inhibitor BILN 2061 (1) is described.  The synthesis is highly convergent and consists of two amide bond formations, one etherification, and one ring-closing metathesis (RCM) step, using readily available building blocks 2-5.  The optimization of each step is described at length.  The main focus of the paper is the study of the RCM step and the description of the main problems faced when scaling up to pilot scale this highly powerful but very challenging synthetic operation.  Eventually, the RCM reaction was smoothly scaled up to produce >400 kg of cyclized product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf2OnRGfj7hrVg90H21EOLACvtfcHk0ljQyFKca6mHbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1KgsL4%253D&md5=c624c44d7818034d362fc8798cb83d09</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjo060285j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo060285j%26sid%3Dliteratum%253Aachs%26aulast%3DYee%26aufirst%3DN.%2BK.%26aulast%3DFarina%26aufirst%3DV.%26aulast%3DHoupis%26aufirst%3DI.%2BN.%26aulast%3DHaddad%26aufirst%3DN.%26aulast%3DFrutos%26aufirst%3DR.%2BP.%26aulast%3DGallou%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DSimpson%26aufirst%3DR.%2BD.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DFuchs%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DSmith-Keenan%26aufirst%3DL.%2BL.%26aulast%3DVitous%26aufirst%3DJ.%26aulast%3DRidges%26aufirst%3DM.%2BD.%26aulast%3DSpinelli%26aufirst%3DE.%2BM.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DDonsbach%26aufirst%3DK.%26aulast%3DNicola%26aufirst%3DT.%26aulast%3DBrenner%26aufirst%3DM.%26aulast%3DWinter%26aufirst%3DE.%26aulast%3DKreye%26aufirst%3DP.%26aulast%3DSamstag%26aufirst%3DW.%26atitle%3DEfficient%2520large-scale%2520synthesis%2520of%2520BILN%25202061%252C%2520a%2520potent%2520HCV%2520protease%2520inhibitor%252C%2520by%2520a%2520convergent%2520approach%2520based%2520on%2520ring-closing%2520metathesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D7133%26epage%3D7145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scola, P. M.</span><span> </span><span class="NLM_article-title">A facile synthesis of 1-substituted cyclopropylsulfonamides</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=725-728&author=J.+Liauthor=D.+Smithauthor=H.+S.+Wongauthor=J.+A.+Campbellauthor=N.+A.+Meanwellauthor=P.+M.+Scola&title=A+facile+synthesis+of+1-substituted+cyclopropylsulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DCampbell%26aufirst%3DJ.%2BA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DScola%26aufirst%3DP.%2BM.%26atitle%3DA%2520facile%2520synthesis%2520of%25201-substituted%2520cyclopropylsulfonamides%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26spage%3D725%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuhart, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomassen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuerborn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kae, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gretch, D. R.</span><span> </span><span class="NLM_article-title">Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">2280</span><span class="NLM_x">–</span> <span class="NLM_lpage">2290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400121t&amp;key=10.1128%2FJVI.80.5.2280-2290.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400121t&amp;key=16474135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400121t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFyhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=2280-2290&author=S.+Palauthor=M.+C.+Shuhartauthor=L.+Thomassenauthor=S.+S.+Emersonauthor=T.+Suauthor=N.+Feuerbornauthor=J.+Kaeauthor=D.+R.+Gretch&title=Intrahepatic+hepatitis+C+virus+replication+correlates+with+chronic+hepatitis+C+disease+severity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo</span></div><div class="casAuthors">Pal, Sampa; Shuhart, Margaret C.; Thomassen, Lisa; Emerson, Scott S.; Su, Tao; Feuerborn, Nathan; Kae, John; Gretch, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2280-2290</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The role of viral factors in the pathogenesis of chronic hepatitis C is unknown.  The objective of the present study was to characterize markers of hepatitis C virus (HCV) infection and replication in liver biopsy specimens obtained from 65 genotype 1-infected subjects, including 31 who were coinfected with human immunodeficiency virus (HIV), and to analyze assocns. between intrahepatic viral markers and hepatitis C disease severity.  The percentages of liver cells harboring HCV genomes (%G) and replicative-intermediate RNAs (%RI) were evaluated using strand-specific in situ hybridization, while HCV core and NS3 antigens were assessed by immunocytochem.  HIV-pos. and HIV-neg. subjects had similar mean grades and stages of liver disease and had similar indexes of HCV infection and replication in liver, even though coinfected subjects had significantly shorter mean disease duration (P = 0.0003).  Multivariate anal. showed that %G was not assocd. with grade or stage of liver disease (P = 0.5 and 0.4, resp.), while %RI was strongly assocd. with liver inflammation (P < 0.001), liver fibrosis (P < 0.001), and serum alanine aminotransferase levels (P = 0.01).  NS3 antigen (but not core) was more frequently detected in HCV RI-pos. vs. RI-neg. specimens (P = 0.028).  These findings demonstrate a link between HCV proliferation and hepatitis C disease severity and suggest similar pathogenic mechanisms in HIV-pos. and HIV-neg. individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkX58TDz-HsbVg90H21EOLACvtfcHk0lhJh5egP_ETJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFyhtrc%253D&md5=fe2211928db49911b3cde3230a5548ea</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FJVI.80.5.2280-2290.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.80.5.2280-2290.2006%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DS.%26aulast%3DShuhart%26aufirst%3DM.%2BC.%26aulast%3DThomassen%26aufirst%3DL.%26aulast%3DEmerson%26aufirst%3DS.%2BS.%26aulast%3DSu%26aufirst%3DT.%26aulast%3DFeuerborn%26aufirst%3DN.%26aulast%3DKae%26aufirst%3DJ.%26aulast%3DGretch%26aufirst%3DD.%2BR.%26atitle%3DIntrahepatic%2520hepatitis%2520C%2520virus%2520replication%2520correlates%2520with%2520chronic%2520hepatitis%2520C%2520disease%2520severity%2520in%2520vivo%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D2280%26epage%3D2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batonga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montpetit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span> </span><span class="NLM_article-title">The liver partition coefficient-corrected inhibitory quotient and the pharmacokinetic–pharmacodynamic relationship of directly acting anti-hepatitis C virus agents in humans</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5381</span><span class="NLM_x">–</span> <span class="NLM_lpage">5386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5381-5386&author=J.+Duanauthor=G.+Bolgerauthor=M.+Garneauauthor=M.+Amadauthor=J.+Batongaauthor=H.+Montpetitauthor=F.+Otisauthor=M.+Jutrasauthor=N.+Lapeyreauthor=M.+Rheaumeauthor=G.+Kukoljauthor=P.+W.+Whiteauthor=R.+C.+Bethellauthor=M.+G.+Cordingley&title=The+liver+partition+coefficient-corrected+inhibitory+quotient+and+the+pharmacokinetic%E2%80%93pharmacodynamic+relationship+of+directly+acting+anti-hepatitis+C+virus+agents+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DBatonga%26aufirst%3DJ.%26aulast%3DMontpetit%26aufirst%3DH.%26aulast%3DOtis%26aufirst%3DF.%26aulast%3DJutras%26aufirst%3DM.%26aulast%3DLapeyre%26aufirst%3DN.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26atitle%3DThe%2520liver%2520partition%2520coefficient-corrected%2520inhibitory%2520quotient%2520and%2520the%2520pharmacokinetic%25E2%2580%2593pharmacodynamic%2520relationship%2520of%2520directly%2520acting%2520anti-hepatitis%2520C%2520virus%2520agents%2520in%2520humans%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5381%26epage%3D5386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montpetit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jutras, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span> </span><span class="NLM_article-title">Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=164-172&author=J.+Duanauthor=C.+L.+Yongauthor=M.+Garneauauthor=M.+Amadauthor=G.+Bolgerauthor=M.+J.+Deauthor=H.+Montpetitauthor=F.+Otisauthor=M.+Jutrasauthor=M.+Rheaumeauthor=P.+W.+Whiteauthor=M.+Llinas-Brunetauthor=R.+C.+Bethellauthor=M.+G.+Cordingley&title=Cross-species+absorption%2C+metabolism%2C+distribution+and+pharmacokinetics+of+BI+201335%2C+a+potent+HCV+genotype+1+NS3%2F4A+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DDe%26aufirst%3DM.%2BJ.%26aulast%3DMontpetit%26aufirst%3DH.%26aulast%3DOtis%26aufirst%3DF.%26aulast%3DJutras%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26atitle%3DCross-species%2520absorption%252C%2520metabolism%252C%2520distribution%2520and%2520pharmacokinetics%2520of%2520BI%2520201335%252C%2520a%2520potent%2520HCV%2520genotype%25201%2520NS3%252F4A%2520protease%2520inhibitor%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26spage%3D164%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i23"><a href="/doi/suppl/10.1021/jm400121t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50288"></div></div></div></div></div><hr /></hr><p class="last">Detailed synthesis of macrocycle <b>21</b>, quinolines <b>22b</b>,<b>c</b>, carbamates <b>2</b>–<b>6</b>, and amides <b>7</b>–<b>20</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400121t/suppl_file/jm400121t_si_002.pdf">jm400121t_si_002.pdf (343.04 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400121t&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm400121t%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-5%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400121t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                501KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679930d8da733cac","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
